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ABSTRACT 
Rodrigo Javier Gonzalez: Dissemination of Yersinia pestis during bubonic plague 
(Under the direction of Virginia L. Miller) 
 
Yersinia pestis is a highly virulent bacterial pathogen with remarkable 
abilities to disseminate in a host. The ability of this Gram-negative bacterium to 
spread and replicate in its host results in high morbidity and mortality in humans. 
Bubonic plague is the most prevalent form of the disease and develops after Y. 
pestis is deposited into the skin of a susceptible host. Little is known about the 
events that occur after inoculation into the skin and that result in movement of 
bacteria to the lymph node that drains this site. Similar questions surround how the 
bacteria progress beyond the lymph node to survive systemically. This work 
focused on the use of a murine model and a fully virulent strain of plague to gain 
insights into how Y. pestis interacts with the host during dissemination. We 
describe an imaging approach to study bacterial dissemination in mice (Chapter 2). 
In this chapter, a bioluminescent strain of Y. pestis was used to track bacterial 
spread in mice by bioluminescence imaging using different routes of infection. We 
also studied the major events that define dissemination from the skin into the lymph 
node and that result in systemic dissemination (Chapter 3). We found that 
dissemination of Y. pestis into lymph nodes is restricted by a bottleneck that 
defines the final population that colonizes the host. By using confocal microscopy, 
we tracked bacteria at different stages of infection and identified important sites 
where host-pathogen interactions occur. Lastly, we established the importance of 
IV	  
	  
an intradermal model of inoculation we implemented after comparing it with a 
subcutaneous model that has been traditionally used in the field (Chapter 4).  
Our study contributes significantly to the understanding of host-pathogen 
interaction during bacterial infections. More specifically, our findings provide 
important information that advances our knowledge on Y. pestis pathogenesis and 
how the bacterium disseminates inside a host. Because of the scope of our 
research, these findings have relevant implications to fields as diverse as bacterial 
pathogenesis, cutaneous immunity, and vaccine development.  
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CHAPTER 1: Yersinia pestis AND PLAGUE 
1.1. Overview 
Yersinia pestis is a Gram-negative bacterium and the etiological agent of 
plague (Stenseth et al., 2008). Mainly because of historical reasons, plague is one 
of the most widely recognized bacterial diseases. Three of the deadliest pandemics 
in history were caused by Y. pestis, making this pathogen a source of fear as well 
as a reminder of the threat that infectious diseases represent (Zietz and 
Dunkelberg, 2004). While the antibiotic era brought the threat of plague pandemics 
to an end, Y. pestis still circulates worldwide in animal reservoirs (Gage and Kosoy, 
2005). These reservoirs represent a threat to human populations that live in close 
proximities and are the source of occasional outbreaks. More important concerns 
are raised when the potential use of Y. pestis as a bioweapon is taken into account 
(Inglesby et al., 2000). In addition, further concerns derive from reports describing 
the existence of antibiotic resistant strains in nature (Galimand et al., 2006).    
Bubonic plague is the most prevalent form of the disease. It originates from 
the bite of an infectious flea; as it attempts to feed, it deposits bacteria into the skin 
(Wimsatt and Biggins, 2009). Despite many years of research, little is understood 
about how Y. pestis interacts with mammalian hosts at the cellular and molecular 
level. This is especially true during bacterial dissemination from the skin into 
deeper tissues. Little is known about the specific responses of the skin to Y. pestis. 
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Bacterial interactions with the host components have been addressed mostly in 
vitro rather than in vivo. In addition, because of the challenges of working with fully 
virulent Y. pestis, most of the research has been conducted with attenuated strains. 
For these reasons, the interactions of Y. pestis with the immune response, 
specifically with the phagocytes, are not fully elucidated. Moreover, the use of less 
than ideal approaches to study plague has generated ideas that are widespread in 
the field. However, these ideas might have little in common with observations made 
in a biologically relevant system where all the components of infection are taken 
into account.   
1.2. Natural history of plague  
In 1894, Alexander Yersin isolated the causative agent of plague, a bacterium 
later known under the name of Yersinia pestis. Many years later, Yersin himself 
proposed a connection between plague and rats, an idea that was expanded by 
Paul-Louis Simond. Simond proposed a central role of fleas in transmission but 
was not able to show convincing evidence (Zietz and Dunkelberg, 2004). The flea 
hypothesis was confirmed in 1914 when Bacot and Martin described Y. pestis in 
the digestive tract of fleas. The conclusion of their report was that bacteria survived 
in fleas forming aggregates that blocked the proventriculus of the insect (Bacot and 
Martin, 1914). This blockage was demonstrated to be important for efficient 
bacterial transmission from flea to host. With this, centuries of unfruitful speculation 
on the causes of plague were over and the paradigm of plague infections was 
established.  
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Ricardo Jorge made an early observation with important consequences for 
plague persistence. Jorge demonstrated that Y. pestis was maintained in animal 
reservoirs in the wild, establishing plague as a zoonosis (Zietz and Dunkelberg, 
2004). Besides explaining the occurrence of sudden outbreaks, this finding meant 
that control and elimination of plague would be a difficult, if not impossible task to 
accomplish. Indeed, plague currently exists in many parts of the globe, mainly in 
rodent reservoirs. The prevalence of Y. pestis in wild animals has been termed 
sylvatic plague. In addition to the role of rodents in the maintenance of Y. pestis, 
other animals are affected by the bacteria and may contribute to plague 
persistence. Lagomorphs (hares and rabbits), ungulates (hoofed mammals), 
marsupials, carnivores, primates, among others, have been described to succumb 
to infection (Gage and Kosoy, 2005). Cold blooded animals and birds do not 
appear to be susceptible to the disease. Sylvatic plague is also important because 
high spread episodes in animals (epizootics) result in the substantial lost of 
members of a species. In the United States, plague is distributed in areas inhabited 
by more than half of the animals considered endangered (Biggins and Kosoy, 
2001). Species that are susceptible to the disease, such as the black footed ferret 
(Mustela nigripes), are considered endangered because of plague (Matchett et al., 
2010).  
How the bacteria are maintained during inter-epizootic cycles is at the moment 
one of the most important questions in the plague field. This is relevant because it 
is during epizootics when humans are at high risk, as they can acquire the fleas 
that abandon dead animals and that look for new sources of blood. Many 
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hypotheses have been proposed but little research has been done to test them. 
One possibility is that the bacteria survive in hosts that are less susceptible to the 
effects of the disease and, thus, play the role of healthy carriers. It has been 
suggested that latency can occur during the winter in ground squirrels during 
hibernation (Bizanov and Dobrokhotova, 2007). These carriers could start new 
cycles of transmission once they are active in the spring. Another possibility is that 
fleas can remain infected with Y. pestis for long periods, during which their ability to 
transmit the bacteria varies. In this case, epizootics would be observed only during 
the periods where optimal transmission by the flea takes place, a phenomenon 
perhaps triggered by changes in temperature, humidity, or availability of a specific 
nutrient in a bloodmeal. In agreement with this hypothesis, it has been shown that 
the source of blood can affect many factors of flea transmission (Eisen et al., 
2008). Feeding fleas on different sources (rat, mouse, and rabbit) affected bacterial 
loads and the ability of fleas to remain infected. Lastly, a bacterial dormant stage in 
the environment has also been proposed. Few studies have addressed this idea 
but one in particular claims to have found an induced dormant state in low 
temperature water (Pawlowski et al., 2011).  
Other less conventional hypotheses have been proposed regarding 
maintenance of Y. pestis in natural settings, but are not generally accepted due to 
a lack of data to support them. One such hypothesis proposes that specific genes 
allow the bacteria to survive and continue colonizing an animal after death 
(Easterday et al., 2011). This could allow the bacteria to survive over extended 
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periods and perhaps to be transmitted to a carrion-eating animal with equal or less 
susceptibility to Y. pestis.  
One or many of the scenarios mentioned above could contribute to the 
maintenance of sylvatic plague but so far none of them have been established as 
relevant. Determining how Y. pestis survives during inter-epizootic events could 
potentially be the next most important discovery in the field.  
1.3. Epidemiology 
Vague descriptions of the spread of plague date back from ancient times. It 
was only in the 14th century, during the pandemic known as the Black Death, when 
more detailed descriptions about disease spread and prevalence were written. 
These are the first examples where prevalence could be linked to symptoms that 
are more or less compatible with plague. Very detailed documents exist from the 
centuries that followed the Black Death. Worth mentioning are the records of the 
Venetian government, which made substantial efforts to control epidemics of 
plague. During the 17th and 16th centuries, the city of Venice relied on a remarkably 
well-structured set of strategies to prevent plague outbreaks (Konstantinidou et al., 
2009). These strategies included isolation of sick individuals to separate islands, 
which constitutes the first example of government control over a population to 
prevent disease spread. As a result, the Venetian republic was one of the very few 
territories in Europe and Asia that, to some extent, was able to control plague. In 
spite of such epidemiological control, plague continued to have devastating effects 
during the next several centuries.  
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Y. pestis is considered to be responsible for three major pandemics in history: 
The Justinian Plague, The Black Death, and the Third Pandemic (Zietz and 
Dunkelberg, 2004). Despite the large number of epidemics caused by Y. pestis, 
humans are considered incidental hosts. Most human cases are caused by 
fleabites in plague endemic foci (Perry and Fetherston, 1997). Transmission to 
humans can only be linked to specific groups of animals, since only some of the 
flea species that parasitize them can also feed on human blood. Squirrels, which 
carry fleas that feed on humans, are the major source of infections in the United 
States (Perry and Fetherston, 1997). Besides fleabites, other less common means 
of transmission exist. Ingestion of raw meat from camel resulted in infection of five 
individuals in the middle east (Abdulaziz A Bin Saeed, 2005). Y. pestis was isolated 
from left over meat and from fleas found in the surroundings where the camel was 
kept. This case is an example of a rare manifestation of the disease termed 
pharyngeal plague that is caused by ingestion of bacteria. Other uncommon means 
of transmission include handling of infected carcasses (Wong et al., 2009).  A field 
biologist acquired the bacteria in the United States during a dissection of a 
mountain lion found dead in the wild. The researcher was found dead in his house 
and Y. pestis bacilli were isolated from his body and from the carcass of the 
mountain lion.  
The World Health Organization (WHO) reported that the number of suspected 
and confirmed human cases of plague worldwide from 1994 to 2003 was 28,530 
(Table 1.1) (Butler, 2009; WHO, 2004). The number of deaths reported was 2015. 
This number might not be accurate because isolated cases are typically not 
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reported. Africa is the most affected continent but plague foci exist in every 
continent. Of importance is the reappearance of cases where the disease had not 
been seen in many years. Eighteen cases of bubonic plague were reported in 2003 
in Algeria, a country that had no reported cases in the previous 50 years (Bertherat 
et al., 2007). Because of similar increases in reported cases in other countries, 
plague has been categorized as a re-emerging infectious disease. It has been 
suggested, however, that amplification and regression of existing sylvatic foci drive 
this apparent re-emergence (Duplantier et al., 2005).  Whether this is true or new 
foci are starting to emerge is unknown. 
Lastly, a role of climate change in plague cases around the world has been 
proposed. This hypothesis states that raising temperatures can influence the three 
factors that are important for plague transmission: fleas, hosts, and bacteria (Ben 
Ari et al., 2011). At a small scale, temperature can influence the ability of bacteria 
to replicate and perhaps to efficiently colonize fleas. At a higher scale, temperature 
affecting local weather can affect flea and rodent density. At an even higher scale, 
temperature can increase the probability of primary hosts establishing contacts with 
secondary hosts such as humans (Ben Ari et al., 2011). 
1.4. Clinical manifestations and treatment 
Depending on the route of bacterial entrance to the body, plague can be 
identified as bubonic, pneumonic, and septicemic. Each route varies in early 
clinical manifestations but all can result in bacterial dissemination into the 
bloodstream.  
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1.4.1. Bubonic plague 
Bubonic plague is the most prevalent form of the disease and it takes place 
after bacteria penetrate the skin (Smego et al., 1999). This can occur when 
individuals handle contaminated material and experience skin abrasions, or most 
commonly, after the bite of an infected flea (Wimsatt and Biggins, 2009). Mortality 
rates range between 50 to 90% (Dennis and Staples, 2009; Prentice and 
Rahalison, 2007).  
During the early stages of infection, pustules can develop in the area of 
contact. Disease progresses as Y. pestis abandons the skin and moves into the 
lymph node that drains this site (Sebbane et al., 2005). The bacteria that reach this 
compartment replicate at remarkably high rates.  Colonization of lymph nodes 
results in severe inflammation causing major enlargement of the tissue (Smego et 
al., 1999). Enlarged lymph nodes are termed buboes, and constitute the hallmark 
of bubonic plague. From the Middle Ages on, the presence of buboes is one of the 
most important signs of bubonic plague infections (Walløe, 2008). Because 
fleabites take place more commonly in the extremities, buboes are typically found 
in the inguinal and axillary regions of the body (Smego et al., 1999).  
 Symptoms of bubonic plague include high fever, myalgia, malaise and painful 
buboes (Crook and Tempest, 1992). During the late stages of infection, Y. pestis 
escapes into the blood stream. This can happen through direct entrance of bacteria 
into the blood from the vessels that irrigate the lymph nodes. Alternatively, bacterial 
can escape through efferent lymphatic vessels to eventually reach the thoracic 
duct. This is the largest lymphatic vessel and the major collector of lymph from 
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other vessels of the body. It serves as a connection between the lymphatic system 
and systemic circulation as it drains into the left subclavian vein. The escape of Y. 
pestis from the lymph node is one of the most understudied aspects of plague. It is 
unknown if specific genes are upregulated in this compartment to either invade 
local blood vessels or to guarantee easy escape from efferent lymphatic vessels.  
Once systemic dissemination occurs, the typical symptoms of sepsis are 
observed. Necrosis in the skin or other parts of the body such as entire limbs can 
occur. Digital gangrene has also been observed (Anisimov and Amoako, 2006). 
This is thought to be caused by bacterial blockage of capillary vessels, which 
results in irregular blood irrigation to the affected areas. Death is mainly caused by 
circulatory collapse and extended internal hemorrhage. In some cases, 
colonization of the lungs develops into secondary pneumonic plague, which can be 
an alternative cause of death.  
1.4.2. Pneumonic plague 
Pneumonic plague is the only form of the disease that can be transmitted 
person-to-person and is considered the most lethal manifestation of plague (Dennis 
and Staples, 2009). A plague patient with bacteria in the lungs can expel bacteria-
containing particles, which in turn can be inhaled by a naïve individual. This 
individual most likely will develop primary pneumonic plague. Patients succumb in 
four to seven days after initial contact with the bacteria. Without prophylaxis, 
mortality rates are nearly 100%. Because Y. pestis can be acquired through 
aerosols, the use of fully virulent strains in research is restricted to biosafety level 3 
(BSL3) laboratories. Furthermore, aerosol dispersion poses a threat to public 
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health as it provides the possibility that Y. pestis could be used as a bioweapon 
(Inglesby et al., 2000). For this reason, Y. pestis is currently categorized as a tier 
one select agent, which entails tight regulations for those who handle the bacteria 
in any setting.  
A murine model of infection suggests that pneumonic plague progresses in 
two phases (Lathem et al., 2005). The pre-inflammatory phase is characterized by 
high levels of bacterial replication in the lung, and the absence of a local immune 
response. This is followed by a pro-inflammatory phase, when cytokine production, 
neutrophil influx, and disruption of the lung architecture are observed. The effects 
of this pro-inflammatory phase are responsible for pneumonia and death. Septic 
shock caused by bacterial escape to the bloodstream might also contribute to 
death.  
During the pro-inflammatory phase, patients experience an array of symptoms. 
These symptoms include coughing, myalgia, malaise and weakness (Crook and 
Tempest, 1992). As pneumonia progresses, shortness of breath, chest pain and 
bloody or purulent sputum are observed. Other symptoms might include diarrhea 
and vomiting. Hemorrhages in the lung fill air spaces with blood, causing 
hemorrhagic pneumonia. Stridor and cyanosis precede terminal events, which 
include respiratory and circulatory collapse, and bleeding diathesis (Anisimov and 
Amoako, 2006).  
1.4.3 Septicemic plague 
Septicemic plague derives from skin inoculations that result in direct passage 
of bacteria to the bloodstream (Dennis and Staples, 2009). In septicemic plague, 
 
	  
11	  
patients do not display any of the lymphatic tissue-related symptoms, such as 
appearance of buboes. Laboratory intradermal models of infection using mice 
rarely result in septicemic plague. However, this changes when flea-murine models 
are employed. Flea infections have been reported to result in septicemic plague 
with no apparent lymph node involvement (Sebbane et al., 2006). It is challenging 
to determine if these cases are truly septicemic plague. This is because the criteria 
used to establish septicemic cases rely mainly on the absence of bubo formation. 
While a true direct passage from skin into blood might occur, an alternative 
explanation could be elimination of bacteria in lymph nodes after they have 
escaped to the bloodstream. Along with pneumonic plague, patients that 
experience septicemic plague rarely survive (Dennis and Staples, 2009).  
1.4.4 Treatment  
The three forms of the disease described above result in high morbidity and 
mortality. Up until the antibiotic era, patient care relied on strategies mostly based 
on superstition or archaic medicine. In more recent times, treatments such as the 
application of local antiseptics and incision of buboes were efficacious in a few 
patients (Anisimov and Amoako, 2006). However, high levels of efficacy were only 
reached with the use of sulfanilamide antibiotics (Carman, 1938). The use of 
tetracycline, streptomycin, chloramphenicol, and more recently, gentamicin and 
amikacin, are currently recommended to treat plague patients (Anisimov and 
Amoako, 2006). While these antibiotics are easy to administer, mortality is still not 
uncommon. This is mainly because of misdiagnosis that derives from the subtle 
and unspecific early symptoms of plague (i.e. myalgia, fever, malaise). 
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Misdiagnosis typically leads to delayed administration of prophylaxis, making these 
drugs inefficacious because bacterial numbers in circulation are too large. 
Important concerns have been raised because of reports that describe antibiotic 
resistant strains circulating in nature (Hinnebusch et al., 2002).  
1.5. Yersinia pestis pathogenesis and host response 
The genus Yersinia includes 15 species and belongs to the 
Enterobacteriaceae family (Zhou and Yang, 2009). Three species of this genus are 
considered pathogenic to humans: Y. enterocolitica, Y. pseudotuberculosis and Y. 
pestis. The first two are enteric pathogens that are acquired via food-oral routes. Y. 
pestis is a non-motile coccobacillus that shares a very high DNA sequence 
similarity with Y. pseudotuberculosis (Dennis and Staples, 2009). It is thought that 
Y. pestis emerged from a Y. pseudotuberculosis clone and subsequently acquired 
multiple genetic traits (Hinnebusch, 2005). These traits gave the bacterium the 
ability to survive in a new life cycle that involved a flea vector and that resulted in 
high pathogenicity to mammals. The three major pandemics thought to be caused 
by Y. pestis are associated with specific biovars. These three biovars are Antiqua, 
Medievalis, and Orientalis and are associated with the Justinian plague, the Black 
Death, and the Third Pandemic, respectively (Prentice and Rahalison, 2007). The 
strain used in this work, CO92, belongs to the biovar Orientalis (Parkhill et al., 
2001). 
1.5.1. Virulence factors 
 Y. pestis and Y. pseudotuberculosis diverge in ways that include gene 
inactivations, deletions, additions, and chromosomal rearrangements (Perry and 
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Fetherston, 1997). yadA and inv constitute examples of gene inactivations. The 
proteins encoded by these two genes are important for Y. pseudotuberculosis to 
cause enteric disease by helping the bacteria with adhesion and invasion of enteric 
tissues. These two genes are inactivated (present as pseudogenes) in Y. pestis, a 
trait that is thought to reflect a switch from an enteric to a vector-born lifestyle 
(Hinnebusch, 1997).  
 All pathogenic yersiniae carry the plasmid pCD1 (also known as pYV), which 
carries genes that encode the Ysc type III secretion system (T3SS) apparatus and 
the Yersinia outer proteins (Yops) secreted by it (Bleves and Cornelis, 2000). 
These genes are essential for abrogating immune responses of the host and, 
elimination of the pCD1 plasmid results in avirulent strains (Huang et al., 2006). 
Many of the Yops have been suggested to play specific roles during infection: 
YopE has been shown to interfere with actin polymerization of phagocytic cells; 
YopH is thought to induce apoptosis; YopM is suggested to be important to prevent 
blood clot formation. Many of the Yops are not fully characterized and their function 
remains to be confirmed in vivo (Amedei et al., 2011).  
In addition to pCD1, Y. pestis carries the plasmid pPla (also known as pPCP1 
or pPst) (Hinnebusch, 1997). This plasmid carries the plasminogen activator gene 
pla, which encodes a factor with proteolytic properties. This gene is involved in 
fibrinolytic and plasmocoagulase activities of Y. pestis. pla has been shown to be 
essential for Y. pestis to cause pneumonic plague (Lathem et al., 2007) and flea-
derived bubonic plague (Sebbane et al., 2006). The same plasmid also carries pst 
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(bacteriocin pesticin), and pim (pesticin immunity protein) (Perry and Fetherston, 
1997).  
A third plasmid, pFra (also known as pMT1), carries ymt (murine toxin) and 
caf1 (capsular antigen) (Zhou et al., 2006). Their functions are not fully understood 
but most studies agree that Caf1 acts an antiphagocytic factor. The importance of 
this protein, however, has been shown to depend on the genetic background of the 
host in experiments using a murine model of bubonic plague (Weening et al., 
2011).  
Another gene that has been shown to be important to abrogate innate immune 
responses is psaA (pH6 antigen). As with caf1, this gene is thought to prevent 
phagocytosis (Huang and Lindler, 2004). Mutants lacking the psaA gene showed 
attenuation during mouse infections (Weening et al., 2011; Zav'yalov et al., 1996).  
1.5.2. Innate immunity and bubonic plague 
The immune response to pathogens can be specific (termed adaptive) or non-
specific (termed innate). Innate immune responses are those that are activated 
against general stimuli that serve as cues for the body to identify invaders. These 
cues are termed pathogen associated molecular patterns (PAMPs) and are 
molecules that serve as building blocks of essential components of pathogens 
(Vance et al., 2009). They are detected in the host by pattern recognition receptors 
(PRRs), which results in the activation of a myriad of systems whose goal is to 
eliminate infection (Diacovich and Gorvel, 2010). While adaptive responses are 
extremely important for controlling many pathogens, they are not thought to play a 
relevant role during normal plague infections. Adaptive immunity starts when 
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specialized cells process molecules produced by a specific pathogen. Long-lasting 
immune responses are then generated specifically against the pathogens that carry 
such molecules. Establishing an adaptive immune response requires 
approximately two weeks. This is twice the time it takes for plague-infected animals 
to succumb to disease (Lathem et al., 2005; Sebbane et al., 2005). For this reason, 
innate immunity is the only branch of the immune response that is believed to be 
relevant to plague pathogenesis and will be the focus of this section.  
Innate immune responses consist of physical barriers, immune molecules, and 
immune cells (Akira et al., 2006). Infection starts when bacteria break the physical 
barriers that protect the body from the environment. Epithelial tissues are examples 
of these barriers, as they prevent entry of bacteria into the body. Upon entrance, 
the bacteria themselves or the damage caused to the surrounding cells trigger the 
release of molecules that serve mostly as alert signals (Nestle et al., 2009). The 
most important molecules the innate immune system uses to combat pathogens 
are complement and cytokines (Kumar et al., 2011; Shi and Pamer, 2011). The 
functions of these molecules are diverse. They can serve as chemoattractants to 
cells of the immune response; modulate expression of genes that will favor 
pathogen elimination; or adhere directly to a pathogen to facilitate phagocytosis. 
Upon cytokine release, cellular-mediated responses are activated. These 
responses rely on specialized lineages of cells with many properties that allow 
them to eliminate intruders. These cells include macrophages, dendritic cells (DC), 
neutrophils, natural killer cells, mast cells, and monocytes (Abraham and St John, 
2010; Kolaczkowska and Kubes, 2013; Nestle et al., 2009; Rescigno, 2002; Shi 
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and Pamer, 2011; Slauch, 2011). Bacterial killing can be achieved by the release of 
molecules that are detrimental to the pathogen. However, killing of bacteria mostly 
occurs intracellularly, after phagocytosis. Any cell of the innate immune response 
that can engulf invaders is termed a phagocyte. Some of these cells are also called 
professional antigen presenting cells. This is because they present molecules from 
degraded pathogens to T cells in lymph nodes (Alvarez et al., 2008). Antigen 
presentation in lymph nodes marks the beginning of adaptive immune responses. 
DCs are the epitome of antigen presenting cells and, thus, are considered a link 
between innate and adaptive immunity (Ueno et al., 2007).  
Another important aspect of innate immunity is inflammation. This mechanism 
of defense can act as a physical barrier to dissemination. In addition, inflamed 
tissues release alarm signals, which are molecules that alert the body about the 
invasion of a pathogen (Kolaczkowska and Kubes, 2013).  
The ability of Y. pestis to prevent phagocytosis is perhaps its most important 
trait. Y. pestis shows multiple genetic traits that reflect the importance of host 
cellular-mediated responses to infection (Durand et al., 2010). Based on the 
degrees of attenuation obtained by the use of deletion mutant strains, the T3SS 
apparatus and some of its translocated proteins have been shown to be the most 
important virulence factors of Y. pestis (Aepfelbacher et al., 2007). Abrogation of 
cellular-mediated innate immune responses is probably the most important activity 
of Y. pestis to survive in the host (DeLeo and Hinnebusch, 2005). The bacteria can 
affect basic activities of a phagocytic cell, such as movement, or its ability to 
produce cytokines to recruit other cells. For this reason, the proteins that help the 
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bacteria accomplish this function are simply known as antiphagocytic factors. In a 
murine model of plague using a reporter system to identify cells targeted by T3SS, 
Marketon et al. found that neutrophils, macrophages and DCs were injected by the 
apparatus (Marketon et al., 2005). In intranasal models that mimic pneumonic 
plague, similar results were shown but the most important group targeted was 
neutrophils (Pechous et al., 2013).  
The great majority of plague studies that address interactions with host cells 
have been conducted in vitro using tissue culture cell lines. The most extensively 
studied cell lineage for these studies is macrophages. This is perhaps because 
macrophage cells and macrophage-like cell lines are readily available and 
relatively easy to work with. Macrophage phagocytosis of Y. pestis grown at a 
temperature of 26°C has been extensively documented (Janssen and Surgalla, 
1969). This is a temperature at which Y. pestis grows inside a flea and one that is 
not conducive to expression of antiphagocytic factors. Most reports affirm that Y. 
pestis survives and replicates inside macrophages (Cavanaugh and Randall, 1959; 
Pujol and Bliska, 2003; Straley and Harmon, 1984). However, the most recent 
literature emphasizes survival rather than growth (Amedei et al., 2011; Klein et al., 
2012). This is perhaps because of high variability that exists between cell lines and 
because observations of substantial intracellular growth are hard to replicate 
(Ponnusamy and Clinkenbeard, 2012). While interactions with macrophages have 
been assessed in a few in vivo murine models, attenuated strains or routes that are 
not biologically relevant are typically used (Charnetzky and Shuford, 1985), making 
the conclusions somewhat limited.  
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Neutrophils are the second most common phagocyte used to study plague 
pathogenesis (Shannon et al., 2013; Spinner et al., 2013). These cells are 
considered the most efficient lineage of the innate response to control any bacteria 
(Kobayashi et al., 2005). As with macrophages, most plague research involving 
neutrophils has relied on in vitro approaches.  Although there are some 
disagreements among different studies, it is largely believed that Y. pestis is 
susceptible in one way or another to the microbicidal effects of neutrophils (Pujol 
and Bliska, 2005). It has been proposed that ingested Y. pestis are eliminated by 
neutrophils regardless of the presence of T3SS. Moreover, extracellular bacteria 
appear to survive in a T3SS dependent manner (Spinner et al., 2008). For this 
reason, it is thought that preventing neutrophil recruitment is beneficial for Y. 
pestis. The outer membrane protein Ail has been suggested to contribute to 
preventing neutrophil recruitment (Hinnebusch et al., 2011). Survival in neutrophils 
has also been reported and is dependent on the two component system PhoPQ 
(O'Loughlin et al., 2010). Recent work using an intradermal murine model of 
bubonic plague imaged neutrophil recruitment into the skin (Shannon et al., 2013). 
In this study, a robust neutrophil response was seen in the dermis during the first 
four hours of infection. The study reported bacteria residing inside neutrophils in 
the skin as well as subversion of neutrophil functions against bacteria at this site. In 
addition, it was proposed that Y. pestis-containing neutrophils are engulfed by 
macrophages (Spinner et al., 2013). This process, termed efferocytosis, has been 
documented in other infections. Efferocytosis has been shown to have major 
implications for the transport of pathogens such as Leishmania to lymph nodes 
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(Peters et al., 2008; Silva, 2010). In summary, Y. pestis might be eliminated by 
neutrophils in some cases and might be able to survive inside them as well. These 
contradictory properties of the bacteria might reflect adaptations of Y. pestis to the 
specific conditions used during experiments. They may also reflect how little we 
understand about neutrophil biology and, perhaps, even diversification.  
An active role of DCs during bubonic plague infections has been suggested 
(Velan et al., 2006; Zhang et al., 2008). This is because these cells move antigen 
from the skin to lymph nodes and could be used by the bacteria to disseminate 
inside the body (Rescigno, 2002; Weiner and Glomski, 2012). However, very little 
research on the interactions of Y. pestis with DCs has been conducted. This could 
be because of the technical challenges that working with this group of cells entails. 
DCs exist in very low numbers in the body and their isolation in high enough 
quantities for experiments is difficult (Inaba et al., 2001). In addition, DCs exist in a 
myriad of subgroups whose functions are unknown. It is difficult to determine what 
is the most appropriate subgroup to use when addressing a specific question 
(Kadowaki et al., 2001). While different reports have looked at some aspects of Y. 
pestis interactions with dendritic cells, in vitro approaches were used in most of 
them (Lindner et al., 2007; Robinson et al., 2008; Velan et al., 2006; Zhang et al., 
2008). In the same study that determined neutrophil recruitment to the dermis, 
Shannon et al. also assessed the role of DCs during infection (Shannon et al., 
2013). The study reports a very modest recruitment of DCs into the dermis and 
little interaction of these cells with Y. pestis. The report concludes that DCs are not 
likely to play a relevant role during infection.  
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1.6. Dissemination from the skin 
Based on its anatomy and physiology, the skin can be divided into three main 
layers: epidermis, dermis, and hypodermis or subcutaneous space. The epidermis 
is in direct contact with the environment and is devoid of blood and lymphatic 
vessels (Combadiere and Liard, 2011). The dermis is the most active layer of the 
skin, physiologically and immunologically (Nestle et al., 2009; Teunissen et al., 
2012). The dermis possesses high numbers of blood vessels, lymphatic vessels, 
and cells of the innate immune response. The presence of these three elements 
makes the dermis unique in its responses to invading microorganisms (Mathers 
and Larregina, 2006; Teunissen et al., 2012). The hypodermis contains blood and 
lymphatic vessels but in low densities. Furthermore, the lymphatic vessels in this 
layer of the skin vary considerably from those found in the dermis. The lymphatic 
vessels found in the dermis, termed superficial lymphatics, are adapted to readily 
take lymph from the surrounding tissue. The lymphatic vessels found in the 
hypodermis, termed deeper lymphatics or collectors, are surrounded by a 
basement membrane and smooth muscle cells (Shayan et al., 2006). These two 
elements make deeper lymphatics less efficient in the uptake of surrounding fluid. 
Furthermore, the lack of resident immune cells in the hypodermis makes this layer 
of the skin a less immunologically competent site in comparison with the dermis 
(Bonnotte et al., 2003; Combadiere and Liard, 2011).  
Very little research has been done regarding how arthropods obtain blood 
from a mammal and it is not well understood what kind of lesion a flea produces 
when probing the skin to take a bloodmeal (Hinnebusch, 2005). A blood feeding 
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arthropod can insert a sucking mouthpart (proboscis) into the skin and feed directly 
from a blood vessel. Alternatively, specialized mouthparts can cut into the skin, 
which produces a lesion filled with fluids from which the arthropod can feed. While 
fleas possess cutting mouthparts, it is not known if they can be used to obtain 
blood directly from blood vessels or if they damage the surrounding area to obtain 
a bloodmeal. Most research has been done on mosquitoes, which were thought to 
probe directly into blood vessels to obtain blood. Recent intravital imaging 
experiments have shown that while that does occur, mosquitoes can also feed from 
other sites of the skin where blood accumulates as they probe (Choumet et al., 
2012). This shows that the question of how a flea feeds might be a very complex 
one and how little we understand about how bacteria are deposited into the skin. 
Most research agrees, however, that the preferred site for blood feeding arthropods 
to obtain a meal is the dermis, and not the subcutaneous space (Chong et al., 
2013). This has also been suggested specifically for plague (Hinnebusch, 2005; 
Sebbane et al., 2006). Determining how exactly the flea inoculates Y. pestis is 
critical for understanding the first moments of dissemination. If bacteria are 
deposited into blood vessels, they will disseminate in a direct route that goes from 
flea into blood. If, on the other hand, fleas probe on the surrounding tissue, bacteria 
must disseminate in a skin-lymph-blood route. Most of the research conducted so 
far suggests that the latter is a closer description of what happens during bubonic 
plague (Sebbane et al., 2005).  
One of the most important questions in infectious diseases is how pathogens 
move from the initial site of contact with the host into deeper organs. Because of 
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technological limitations, however, direct approaches to address this question are 
not readily available. Two possibilities exist as to how bacteria travel from the skin 
to lymph nodes through lymphatics. The first possibility involves bacteria traveling 
with the flow of lymph. In this case, bacteria are deposited into the skin and the 
pressure of lymph itself, along with the contractions of lymphatic vessels could 
drive movement to lymph nodes (Hegde et al., 2011). Knowledge on the lymphatic 
system in general is very limited, and the physiology of particle movement through 
it is not well understood. Perhaps for this reason, the possibility of pathogens 
moving with the flow of lymph in lymphatic vessels is scarcely addressed in the 
literature.  
The second possibility is that pathogens travel from the site of inoculation into 
lymph nodes inside phagocytic cells. This idea is the most widely accepted in fields 
beyond plague research. However, this notion is, with very few exceptions, merely 
speculative. In the case of plague, the most accepted model states that upon 
inoculation, Y. pestis does not yet express antiphagocytic factors and thus, it is 
susceptible to phagocytosis. This has lead to the notion that Y. pestis has an 
intracellular phase during early stages of infection. Moreover, it has been proposed 
that intracellular phases are necessary for the bacteria to travel from the skin to the 
lymph node that drains this site (Zhou et al., 2006). This is based on the normal 
function of antigen presenting cells, which travel to lymph nodes once they have 
engulfed antigen. In this way, Y. pestis would reach the lymph node using a 
phagocyte as a Trojan horse (Weiner and Glomski, 2012). Once in the lymph node, 
the bacteria could exit the phagocytic cell for further colonization of this 
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compartment. A “Trojan Horse” model of bacterial dissemination has been 
proposed for other pathogens (Guidi-Rontani, 2002). However, the model has 
received only modest experimental support (Mihret, 2012).  An alternative model of 
dissemination has been proposed for Bacillus anthracis. In this alternative model, 
in addition to intracellularly, bacteria can also disseminate freely without the need 
of a phagocytic cell (Weiner and Glomski, 2012). Supporting a phagocyte-free 
model, a study on Salmonella abortusovis found that during the first 90 minutes of 
dissemination, 80% of bacteria are found in lymph vessels traveling freely to lymph 
nodes (Bonneau et al., 2006).  
Recent advances in in vivo work and imaging are opening the possibilities of 
studying in more detail Y. pestis dissemination from the skin to the lymph nodes. 
Much experimental support will be needed for the field to accept a model where an 
intracellular stage is not required for bacteria to disseminate from the skin into 
lymph nodes and deeper organs.  
1.8. Significance 
Bacterial infections are detrimental to human health and can be lethal. While 
some research has been conducted on bacteria or the immune response, studies 
that describe the interactions of both are scarce. This is important because of the 
appearance of antibiotic resistance in many bacterial species that affect humans. 
New strategies to treat bacterial infections are needed but the lack of information 
on the physiology of host-pathogen interactions has been an impediment to 
advances. The threat of bacterial infections to human health is essentially defined 
by the capacity of bacteria to disseminate in the host. The remarkable ability of Y. 
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pestis to cause disease is strictly linked to its proficiency to disseminate in the host. 
This makes it an ideal model to study bacterial dissemination.  Understanding Y. 
pestis dissemination has the potential of providing valuable information that will 
result in new strategies to control or even prevent bacterial infections. In addition, 
studying host-pathogen interactions in vivo provides invaluable information with 
relevant implications to other fields such as vaccine development.   
1.7. Figures and Tables 
 
Figure 1.1.  Inflammation of the lung during pneumonic plague.  
During a pre-inflammatory phase, bacterial growth and little or no damage to the 
lung architecture is observed. At later time points (48 hours after intranasal 
inoculation), high levels of inflammation are detected. Image from (Pechous et al., 
2013). 
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Figure 1.2. Skin micrographs showing mosquito-feeding patterns.  
(A) Proboscis inside blood vessel. (B-E) Proboscis inserted perpendicular to the 
blood vessel. (F and G) types of blood feeding: proboscis located in the pool of 
blood (F) and sucking up blood from a pool of blood distant from the blood vessel. 
Blood vessels appear pink and the proboscis appears brown. Image from 
(Choumet et al., 2012). 
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Country Number of cases Case-fatality rate (%) 
Congo 3619 10 
Tanzania 3527 7 
Mozambique 2387 1 
Vietnam 1331 6 
Malawi 900 2 
Uganda 654 17 
Peru 631 3 
Zimbabwe 417 8 
China 357 7 
 
Table 1.1: Cases of human plague in 1994-2003 in the countries that reported 
>100 confirmed or suspected cases.  
Adapted from (Butler, 2009) 
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CHAPTER 2: BIOLUMINESCENCE IMAGING TO TRACK BACTERIAL 
DISSEMINATION OF Yersinia pestis USING DIFFERENT ROUTES OF 
INFECTION IN MICE 
 
2.1. Overview 
Introduction: Plague is caused by Yersinia pestis, a bacterium that disseminates 
inside of the host at remarkably high rates. Plague bacilli disrupt normal immune 
responses in the host allowing for systematic spread that is fatal if left untreated. 
How Y. pestis disseminates from the site of infection to deeper tissues is unknown. 
Dissemination studies for plague are typically performed in mice by determining the 
bacterial burden in specific organs at various time points.  
Methods: To follow bacterial dissemination during plague infections in mice we 
tested the possibility of using bioluminescence imaging (BLI), an alternative non-
invasive approach. Fully virulent Y. pestis was transformed with a plasmid 
containing the luxCDABE genes, making it able to produce light; this lux-
expressing strain was used to infect mice by subcutaneous, intradermal or 
intranasal inoculation. 
Results: We successfully obtained images from infected animals and were able to 
follow bacterial dissemination over time for each of the three different routes of 
inoculation. We also compared the radiance signal from animals infected with a 
wild type strain and a Δcaf1ΔpsaA mutant that we previously showed to be 
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attenuated in colonization of the lymph node and systemic dissemination. Radiance 
signals from mice infected with the wild type strain were larger than values 
obtained from mice infected with the mutant strain (linear regression of normalized 
values, P < 0.05).  
Conclusions: We demonstrate that BLI is useful for monitoring dissemination from 
multiple inoculation sites, and for characterization of mutants with defects in 
colonization or dissemination. 
2.2. Introduction 
Yersinia pestis is a highly virulent Gram-negative bacterial species that infects 
mammals and causes plague. Plague is a lethal disease known for its important 
role in history, mainly as the cause of the Black Death (Perry and Fetherston, 1997; 
Zhou and Yang, 2009; Zietz and Dunkelberg, 2004) . Due to the emergence of 
antibiotics (Anisimov and Amoako, 2006) , plague no longer poses the same threat 
to public health as it did in the past. However, the disease is still present in almost 
every continent (Gage and Kosoy, 2005)  causing fatalities that, during the last two 
decades, have fluctuated between several hundred to several thousand deaths per 
year (Stenseth et al., 2008) . Plague is maintained in sylvatic animal reservoirs, 
and human populations that are in close contact with these reservoirs are at high 
risk (Bitam et al., 2010) . Chemotherapy is efficacious only if administered early 
after infection and untreated individuals succumb to plague in less than a week. 
Furthermore, public health concerns have been raised because of reports of drug 
resistant strains in endemic foci (Galimand et al., 2006) .   
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The disease manifests after inhalation of bacteria suspended in aerosols 
(pneumonic plague) or through contact with broken skin (bubonic and septicemic 
plague)  (Prentice and Rahalison, 2007; Smiley, 2008). While pneumonic plague is 
the most virulent form of the disease, bubonic plague is the most prevalent perhaps 
due to its dynamics of transmission, for which a flea vector is essential (Wimsatt 
and Biggins, 2009) . Little is known about how Y. pestis disseminates within the 
host after infection. It is known, however, that at some point after infection, Y. 
pestis expresses a set of genes that impair host immune responses (DeLeo and 
Hinnebusch, 2005; Marketon et al., 2005; Matsumoto and Young, 2009) . These 
factors are thought to be essential for bacterial dissemination. Dissemination during 
bubonic plague traditionally has been studied through experiments where different 
organs from infected mice are harvested at various time points post inoculation. 
Harvested organs are then homogenized and plated to obtain bacterial burden. 
These experiments have suggested that Y. pestis travels from the site of infection 
to draining lymph nodes (LN) prior to disseminating throughout the rest of the body 
(Guinet et al., 2008; Sebbane et al., 2005) . Bacterial burden data from these 
experiments give a snapshot of a very narrow window (a specific organ at a 
specific time) through the course of infection.  Furthermore, the approach is 
invasive, requires a large number of animals, and animals must be sacrificed at 
each time point making it impossible to keep track of the progression of infection on 
the same group of individuals.  
In vivo bioluminescence imaging (BLI) is an approach that has been used to 
detect light-emitting cells inside of small mammals (Massoud and Gambhir, 2003) .  
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Using BLI, researchers have described and studied dissemination of viral, parasitic 
and bacterial pathogens within a host in a non-invasive manner (Hutchens and 
Luker, 2007; Hyland et al., 2008; Kong et al., 2009; Zincarelli et al., 2008) . Thus, 
the same group of animals can be imaged for as long as desired over the course of 
infection. The system requires that the pathogen produce luminescence, and 
infected animals are then imaged with a high-sensitivity camera that detects very 
small amounts of light. Non-luminescent bacteria can be genetically modified to 
express the lux genes (luxCDABE), which encode a bacterial luciferase and other 
enzymes which are necessary to generate luciferin (Contag and Bachmann, 2002). 
In the presence of oxygen, luciferin is converted into oxyluciferin in a reaction 
catalyzed by luciferase and of which light is a byproduct (Hastings, 1996) . We 
transformed Y. pestis CO92 with plasmid pGEN-luxCDABE that contains the 
luxCDABE genes (Lane et al., 2007) . Using this strain of Y. pestis expressing the 
lux genes we determined that it is suitable for in vivo BLI after subcutaneous, 
intradermal and intranasal inoculation. In addition, we determined that BLI is 
suitable for the study of mutant strains that are attenuated or defective in 
dissemination or colonization during infection.  This extends the findings of a recent 
report demonstrating the suitability of BLI to study Y. pestis infections by the 
subcutaneous route of inoculation (Nham et al., 2012) . 
BLI technology offers a new perspective to study the spread of Y. pestis in the 
host.  This technology could be adopted in the future as an alternative to 
experiments that measured bacterial burdens in specific organs, facilitating the 
discovery and study of genes that are important in pathogenesis. 
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2.3. Methods  
2.3.1. Bacterial strains and cultures 
Y. pestis CO92 and Y. pestis CO92 Δcaf1ΔpsaA were transformed with pGEN-
luxCDABE (Lane et al., 2007) . This plasmid contains the Hok/Sok toxin/antitoxin 
system enabling plasmid maintenance in vivo without antibiotic selection. 
Throughout the rest of the document we will refer to Y. pestis CO92 transformed 
with the pGEN-luxCDABE plasmid as Yplux+, to Y. pestis CO92 Δcaf1ΔpsaA 
transformed with the same plasmid as YpΔcaf1ΔpsaA lux+ or simply as “double 
mutant” and to the pGEN-luxCDABE plasmid itself as pGEN-lux. Bacteria 
transformed with pGEN-lux were cultured in the presence of carbenicillin at 100 
µg/mL, unless BHI alone is stated as growth medium. Bacteria were plated on 
brain heart infusion (BHI) agar (BD Biosciences, Bedford, MA) plates and 
incubated for 48 h at 26°C. For intranasal inoculations, liquid cultures were 
incubated at 37°C in the presence of 2.5 mM CaCl2 as previously described 
(Lathem et al., 2005) . For subcutaneous and intradermal inoculations, liquid 
cultures were incubated at 26°C for 15 h. All strains (Yplux+, YpΔcaf1ΔpsaA lux+ 
and Y. pestis lacking pGEN-lux) showed comparable optical density (OD600) values 
after culturing in liquid broth. To obtain the final inocula for all infections, liquid 
cultures were serial diluted in phosphate buffered saline (PBS). All procedures 
involving Y. pestis were conducted under strict biosafety level three conditions.  
2.3.2. Animal infections and tissues 
Five-to-ten-week old female C57BL/6J or B6(Cg)-Tyrc-2J/J mice (Jackson 
Laboratory, Bar Harbor, ME) were subjected to subcutaneous (SC), intranasal (IN) 
40 
	  
or intradermal (ID) inoculation after providing anesthesia (2% isoflurane for SC and 
ketamine/xylazine for IN and ID).  For SC inoculations, a volume of 100 µL was 
injected in the subcutaneous space at an anterior cervical site. The ear pinna was 
injected with a volume of 10 µL for ID inoculations. A volume of 20 µL was 
delivered into the left nostril of the animal for IN inoculations. The inoculum for the 
SC and ID inoculations was ~200 CFU, and ~104 CFU for the IN inoculation.   
For the determination of plasmid stability and strain characterization 
experiments, superficial cervical lymph nodes, spleens and lungs were removed 
from SC-infected mice after sacrificing the animals by injection of sodium 
pentobarbital. Plasmid stability was assessed by comparing bacterial counts after 
plating on BHI alone and BHI with carbenicillin.  Strain characterization was 
determined by comparing bacterial counts of Yplux+ against Y. pestis lacking the 
plasmid.   
All procedures involving animals were approved by the University of North 
Carolina and Duke University Animal Care and Use Committees, protocols 11-128 
and A185-11-07, respectively.  
2.3.3. In vivo Imaging 
To enhance signal detection, the fur was shaved from the ventral and cervical 
regions of the mice with an electric razor two days before inoculation. Animals were 
anesthetized with 2% isoflurane during the entire imaging process, except for the 
time point 0 h post inoculation (hpi) for IN and ID, where the animals were still 
under the sedation from the ketamine/xylazine treatment. Prior to imaging, mice 
were placed in an animal isolation chamber (Caliper) to maintain containment of Y. 
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pestis outside the biosafety cabinet. We used four mice per group, as this is the 
maximum number of mice that can be placed in the isolation chamber to be imaged 
at one time. Mice were imaged with an IVIS Spectrum instrument (Caliper) at 0, 6, 
24, 48, 72 and 96 hpi, unless animals died or had to be sacrificed because of 
advanced signs of plague. The same group of mice was imaged at each time point. 
Every image was taken after placing the mice in the isolation chamber in the same 
order relative to one another. After imaging the last time point, mice were sacrificed 
with an overdose of isoflurane and one animal per group was dissected.  The 
dissected individual was imaged to identify luminescence from specific organs. 
Organs were then removed from the animal and imaged individually to confirm the 
origin of signal.  The remaining animals were sacrificed and their organs (LN, 
spleens or lungs) were removed, macerated and plated to compare bacterial load 
with previous reports for each model and to confirm plasmid stability as described 
above.  Radiance signal was measured in photons/sec/cm2/steradian and analyzed 
using Living Image Software V.4.2 (Caliper). Radiance signal from a specific site 
(site of inoculation or abdomen) was quantified by defining a region of interest 
(ROI), which was drawn and measured using the Living Image Software (Caliper).  
Radiance background levels were obtained by measuring radiance from a ROI 
(from either site of inoculation or abdomen) of all animals imaged at 0 hours after 
inoculation. When signal was detected from one site (e.g. the neck) and not from a 
second site (e.g. the abdomen), the light emitting site from which signal was 
detected was covered with black opaque paper to increase image sensitivity. A 
specific site was considered to be negative (lacking signal) if no signal was 
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observed after covering all other irradiating sites or if quantification of signal was 
below background levels. Radiance values from each ROI were transformed into 
log values to normalize their distribution. Linear regression analysis of these values 
was performed in STATA 12 (Stata Corp, College Station, TX) to test differences in 
average radiance between groups. A two sided P value <0.05 was set to determine 
statistical significance.  
2.4. Results  
2.4.1. The pGEN-luxCDABE vector is stable in Y. pestis during infection 
Bacteria carrying a reporter plasmid could potentially lose it at a specific site or 
time point during infection. A subpopulation lacking the plasmid could result in false 
negatives or decreases in signal detection that are not necessarily related to lower 
numbers of bacteria. To determine if pGEN-luxCDABE (pGEN-lux) was maintained 
during Y. pestis infections, we performed a kinetic study with mice infected with 
CO92 carrying pGEN-lux. Mice were inoculated subcutaneously (SC) and LN 
harvested at 24 hours post inoculation (hpi), LN and spleens harvested at 48 and 
72 hpi, and LN, spleens and lungs harvested at 96 hpi. Homogenates of each 
organ were plated on BHI and BHI with carbenicillin.  Bacterial enumeration 
showed no differences between the two growth conditions, indicating that pGEN-
lux is stable in vivo up to 96 hpi in all organs tested (Figure 2.1). Additionally, 
organs from all animals imaged in this study were also plated on BHI and BHI with 
carbenicillin (after last imaging time point). We observed the same levels of 
plasmid stability that we report in Figure 1 (data not shown).  
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Another important control experiment was to determine if pGEN-lux impacted 
the virulence of Y. pestis. Mice were inoculated with either Y. pestis alone or Y. 
pestis carrying pGEN-lux. Both groups of mice displayed signs of plague infection 
and mortality at similar times. However, the bacterial burden in tissues from mice 
infected with Y. pestis carrying pGEN-lux was lower in comparison to tissues from 
mice infected with Y. pestis without the plasmid (Figure 2.2). While bacterial counts 
suggest that pGEN-lux might cause a slight delay in the progression of infection, 
overt signs of plague were observed in all mice infected with either strain at 
comparable times. Additionally, all mice infected during our BLI experiments died at 
times expected from infections with a wild type strain. Since all strains used for BLI 
will carry the same plasmid, relative virulence attributes will be comparable despite 
the slight attenuation caused by pGEN-lux. 
2.4.2. BLI of Y. pestis after subcutaneous infection 
In order to determine if BLI would be a suitable method for following 
dissemination or colonization of Y. pestis in vivo, we turned to the well-
characterized subcutaneous model of infection (Cathelyn et al., 2006) . C57BL/6J 
mice were inoculated SC with Yplux+, and the mice imaged at 0, 6, 24, 48, 72 and 
96 hpi. Although the radiance levels were initially low, all animals had signal at the 
site of infection (neck) at 6 hpi, and the signal appeared to increase during the 
course of infection (Figure 2.3A). At 72 hpi, the region of radiance appeared to 
have two separate high intensity spots. The localization of these spots coincides 
with the approximate location of the superficial cervical LNs to which the site of 
infection is predicted to drain. Signal was also detected from the abdomen at 72 
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hpi. However, because of its low intensity, this signal is not evident in Figure 3A. All 
images in Figure 3A are standardized to the same radiance scale, thus low 
intensity spots are not visible. Low intensity spots, however, are visible when high 
intensity spots are covered. After covering high intensity spots from the neck with 
black opaque paper, we could visualize signal from the abdomen at 72 hpi (Figure 
2.3B). Signal from the abdomen was not visualized before 72 hpi but quantification 
above background levels was obtained at 48 hpi (Figure 2.6C). At 96 hpi, radiance 
in the abdominal region increased in intensity (Figure 2.3A and B). From this and 
previous experiments, we observed that the presence and intensity of this signal 
tends to be variable among individuals. Also, from previous experiments where we 
imaged mice beyond 96 hpi, we determined that the presence of this signal, 
especially when high in intensity and spread in size, can be used as a predictor of 
death within the following 24 h. At time points subsequent to detection of light from 
the abdomen, signal was evident at sites where the skin was not covered by fur, 
such as the tail (data not shown). This might be the result of early stages of 
septicemia, where light from bacteria circulating in blood is only detectible from 
superficial vascularized tissue, such as the skin.  At the latter stages of infection 
(>96 hpi), septicemia is evident as signal that can be detected from the entire 
animal.  
Experiments in which bacterial load was measured showed that the LN are the 
first organs to be colonized, followed by deeper tissues (e.g. spleens and livers) 
(Sebbane et al., 2005) . The resolution provided by the BLI system, however, does 
not allow us to be certain that signal from the neck and abdomen comes from these 
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organs. Therefore, mice were dissected to determine that signal indeed originated 
from LN, spleens and livers. These organs, along with the patch of skin where 
bacteria were inoculated, also were imaged individually at 96 hpi and found to emit 
light (Figure 2.3C). Thus, origin of light in specific organs is consistent with 
previous data measuring bacterial burden by plating macerated tissues.  
2.4.3. Dynamics of bacterial dissemination after intradermal infection in the ear 
pinna 
Having established that BLI is a useful method to monitor dissemination 
following a SC infection, we wanted to determine the dynamics of dissemination of 
plague bacilli after intradermal (ID) infection. This model is rarely used for plague 
studies despite the fact that it may mimic a fleabite more closely than a SC 
inoculation (Guinet and Carniel, 2003) . We employed the ear pinna as the site of 
infection to guarantee that no subcutaneous tissue is reached (Guinet and Carniel, 
2003) . In this model, the draining LN is the superficial parotid LN [as identified 
from (Van den Broeck et al., 2006) ], which is distant from the site of infection. 
Thus, signal from the site of infection can be isolated from signal from the draining 
LN, a distinction not easily discerned in the SC model. Because the superficial 
parotid LNs are located deeper in the neck, we opted to infect B6(Cg)-Tyrc-2J/J 
mice. These mice differ from C57BL/6J in that pigment is absent from their skin. 
Using mice lacking skin pigments can increase light detection due to less 
absorption of light by the skin. Thus, the B6(Cg)-Tyrc-2J/J mice were a good 
alternative to maximize detection from small deeper tissues (i.e. superficial parotid 
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LNs) without compromising our well characterized C57BL/6J model for bubonic 
plague.   
The ear pinna was inoculated with ~200 CFU and animals were imaged at 
different time points (Figure 2.4A). Low levels of signal from the site of infection 
could be detected in some animals at 6 hpi (data not shown). However, at 24 hpi, 
strong signal was consistently detected in the ear.  In addition, some of the mice 
had detectible signal in the right side of the neck, approximately where the 
superficial parotid LN is located. At 48 hpi light signal from the site of infection 
appeared to increase considerably. At this same time point, signal from the parotid 
LN increased dramatically, and light was detected in the abdomen and rest of the 
body in some animals, indicating systemic dissemination. At 72 hpi only one mouse 
had survived and it showed high levels of signal from the whole body, indicating 
advanced stages of septicemic dissemination. The right superficial parotid LN was 
confirmed as the highest source of radiance from the neck after dissection of this 
mouse (Figure 2.4B). As previously reported for latter stages of infection (Sebbane 
et al., 2005) , the LN that drains the site of infection was not the only LN that 
appeared to be colonized. However, the superficial parotid LN that drains the site 
of infection (white asterisk, Figure 2.4B) appeared to emit higher levels of radiance 
in comparison to other LNs. Isolated spleens and livers were imaged to confirm 
them as the source of signal from the abdominal area (Figure 2.4B).  
2.4.4. Bacterial dissemination during pneumonic plague 
Pneumonic plague is less common but more fulminant than bubonic plague, 
and is the only form of the disease that can be transmitted directly from human to 
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human (does not require a flea vector). We used BLI to follow dissemination of Y. 
pestis after intranasal inoculation, a well-characterized model for pneumonic 
plague (Lathem et al., 2005) . Lung tissue is the primary tissue colonized by Y. 
pestis during pneumonic infections. Because the lungs reside in the thoracic cavity 
covered by other organs and bone, we again used B6(Cg)-Tyrc-2J/J mice to 
increase the probability of detecting signal from lung tissue.   
In some isolated cases, radiance was detected from the abdomen and from 
feces at 6 hpi (data not shown). This signal was not detected at any latter time 
points and presence of abdominal or fecal signal did not appear to alter the course 
of infection in the animals where it was detected. 
Very little light was detected in the mice at 24 hpi, at which time some mice 
showed signal from different regions in the neck or on the head (Figure 2.5A). At 
48 hpi, light was detected in all animals, mainly from the mid and upper thorax 
(Figure 2.5B).  Radiance spread and intensity increased considerably at 72 hpi, a 
time at which all mice showed pronounced signs of disease. Immediately after 
imaging at 72 hpi, one of the four mice in the group was sacrificed and dissected to 
determine the source of light. The lungs were determined to be the source of 
luminosity from the thorax, and light from this organ was confirmed to be unique to 
IN infections as animals infected using other routes (e.g. ID, Figure 2.5C) did not 
show signal from the lungs. Additionally, we observed that IN-inoculated animals 
showed signal from the tip of the nose (visible in Figure 2.5C) indicating that 
bacteria were present at the site of inoculation at 72 hpi. Upon dissection of the 
lungs, we noticed that part of the organ was necrotic in appearance; imaging of 
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isolated lungs showed that the necrotized tissue produced higher levels of signal 
(Figure 2.5D) in comparison to other areas of the lung. While Figures 2.5C and 
2.5D show data from only one mouse, we performed this experiment multiple times 
and in all cases we made the same observations mentioned above (data not 
shown).   
2.4.5. BLI to identify mutants with defects in dissemination or colonization 
One of the goals of this study was to determine whether mutants with a defect 
in colonization and/or dissemination could be identified by BLI. As proof of concept, 
we compared radiance from mice infected with Yplux+ or YpΔcaf1ΔpsaA lux+ 
mutant. Caf1 and PsaA previously were shown to play a role in dissemination and 
colonization in an additive manner (Weening et al., 2011) . The SC model of 
infection and C57BL/6J mice were chosen for this comparison because the 
colonization phenotype of the Δcaf1ΔpsaA strain was originally tested using this 
model. BLI revealed that the Δcaf1ΔpsaA strain was attenuated in dissemination or 
colonization to deeper tissues from the LN, in agreement with previous work 
(Weening et al., 2011)  (Figure 2.6A and B). Radiance measurements allowed us 
to determine that signal intensity in the neck was lower in animals infected with the 
double mutant strain in comparison to those infected with Yplux+, indicating that 
colonization of the LN by the Δcaf1ΔpsaA lux+ mutant also was impaired compared 
to wild type, in agreement with previous work (Weening et al., 2011)  (Figure 2.6C). 
Differences of radiance values from mice infected with Yplux+ against 
Δcaf1ΔpsaAlux+ attained statistical significance at 24, 48, 72 and 96 hpi (linear 
regression analysis of normalized values, P < 0.05).  
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Mice infected with the Δcaf1ΔpsaA strain never displayed detectible signal 
from the abdomen at any time point (Figure 2.6A). The radiance values from the 
abdomen of these mice were below background levels at each time point 
examined. These radiance values were subjected to regression analysis and 
determined to be significantly different from the values obtained from mice infected 
with Yplux+ at 48, 72 and 96 hpi.  To determine if the absence of signal in 
YpΔcaf1ΔpsaA lux+-infected mice was due to extremely low levels that were 
blocked by skin or other tissue, we dissected the mice and imaged isolated spleens 
and livers at 96 hpi.  No signal was detected from the individual organs (Figure 
2.6B).  In addition, all animals infected with the Δcaf1ΔpsaA mutant survived past 
96 hpi and never showed any signs of disease. We continued to image these 
animals up to 168 hpi, and found that the signal from the neck never disappeared 
and that bacteria appeared to be contained at this site (data not shown). Overall, 
imaging from mice infected with YpΔcaf1ΔpsaA lux+ confirmed previous findings in 
C57BL/6J where bacteria were detected in LN, but at lower numbers in comparison 
to mice infected with a wild type strain, and never or rarely were detected in 
spleens (Weening et al., 2011) . 
2.5. Discussion  
Plague is a disease with devastating effects on the host that are fatal if left 
untreated. These effects are the result of the ability that Y. pestis displays to 
suppress host immune responses and to promote systemic dissemination at 
remarkably high rates. Numerous studies have described many virulence factors 
that are essential to suppress host immune responses (Price et al., 2012; Zhou and 
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Yang, 2009) . The direct contributions of these virulence factors to bacterial 
dissemination, however, are still unclear. The study of dissemination per se is a 
field that is lagging behind in plague research. BLI is a tool that allows for the 
visualization of a pathogen in a host during infection and a very promising 
alternative to better understand Y. pestis dissemination.  A recent report described 
the use of BLI in a subcutaneous (SC) model of bubonic plague (Nham et al., 
2012) . In this report, the pGEN-luxCDABE plasmid was described to have no 
effect on the virulence of Y. pestis and to be suitable for BLI as luminosity 
correlated with bacterial counts in vivo; our results confirmed and expanded upon 
these findings.  Our goal was to determine whether BLI could be used to follow 
dissemination and colonization of Y. pestis in mice after using different routes of 
inoculation that closely mimic bubonic and pneumonic plague. Moreover, we tested 
whether BLI could be used to detect mutants with defects in colonization or 
dissemination.  
After inoculation with a strain of Y. pestis that contains pGEN-luxCDABE, we 
showed that animals can be imaged through the course of infection in such a way 
that bacterial spread could be followed over time for three different models of 
infection. Our results from the SC inoculation model support the previous notion 
that, during bubonic plague, Y. pestis travels from the site of inoculation to the 
proximal lymph node prior to dissemination to deeper tissues (Sebbane et al., 
2005) . We observed that bacteria were maintained at the site of inoculation during 
the course of infection, as previously reported for ear intradermal (ID) infections 
(Guinet et al., 2008) . For both, the SC and ID models, the bacterial population at 
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the site of inoculation appeared not only to be maintained, but also to expand. 
However, while we quantified signal from the site of infection in the SC-inoculated 
animals, we cannot conclude such signal comes from the skin alone. In our SC 
model, the patch of inoculated skin is located in an anatomical position on top of 
the superficial cervical LNs and thus, both, skin and LNs, are imaged as a single 
source of radiance. We could determine that signal was coming partly from the site 
of inoculation after removing the patch of skin and imaging it individually. This 
complication is minimized in the ID model, where the site of inoculation (ear pinna) 
is distant from the draining LN (superficial parotid LN). While an increase over time 
in signal intensity from the ear was observed, we were not able to quantify the 
signal, as it was difficult to place the ears of all mice at the same position inside of 
the animal isolation chamber.  
Images taken during the first hours following intranasal (IN) infections 
suggested that, in isolated cases, at least part of the inoculum can go to the 
stomach. The IN route requires delivering small drops of inoculum into one of the 
nostrils (total volume of 20 µL), and some of this inoculum could be swallowed 
rather than inhaled. Signal from the stomach never seemed to last beyond the 6 
hpi time point, suggesting that gastric infections with Y. pestis in these mice are 
cleared quickly.  We also observed that the feces of half of the mice produced 
detectible signal, indicating that Y. pestis was being shed. This was only observed 
at very early time points (6 hpi), indicating that bacteria were fully shed from the 
gastrointestinal tract by 24 hpi.  In humans, it has been shown that transmission 
can occur after ingestion of contaminated food (Arbaji et al., 2005) . While mice are 
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coprophagous, it is not know whether a fecal-oral route could be a mechanism for 
Y. pestis to disperse or infect other individuals. Detecting signal from the tip of the 
nose also opens the question whether bacteria could be transmitted to other 
individuals with whom food and water are shared. We do not know whether signal 
from the stomach or the tip of the nose would still be present after an aerosol 
infection, a route that pneumonic plague is assumed to be transmitted in nature. All 
mice, independent of the presence of signal from the stomach or feces, showed the 
same progression of infection with comparable levels of signal from the thorax.  
More importantly, all animals showed signs of disease and mortality at very similar 
times. This observation suggests that the fraction of the inoculum that may go to 
the gastrointestinal tract has no effect on the overall pneumonic infection.  The low 
number of mice used during BLI is one of its more important advantages. However, 
it can also be a disadvantage because of the variability in bacterial load for a 
specific organ from animal to animal and sudden death, both inherent aspects of 
plague infections.  The differences in the levels of significance from time point to 
time point when comparing radiance values between the wild type and double 
mutant infected animals are due to this high variability of bacterial load and death. 
Despite these challenges, we found that BLI is a suitable method for studying 
dissemination/colonization of Y. pestis in three separate models of plague, and that 
significant differences in radiance could be detected between wild type and a 
mutant of modest attenuation using relatively few mice.  
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2.6. Figure and Tables 
 
 
 
Figure 2.1. Bacterial loads in C57Bl/6J mice infected subcutaneously with 
pGEN-luxCDABE-carrying Y. pestis. 
Animals were infected with ~200 CFU at a cervical site. Organs were harvested 
and plated for bacterial counts at the indicated hours post inoculation on BHI alone 
(gray symbols) and BHI + carbenicillin (white symbols). Bacterial numbers are 
reported in CFU/g of tissue. Each mark represents a value from a single organ and 
the horizontal lines represent the median of the group.  Superficial cervical lymph 
nodes are represented as circles, spleens as squares, and lungs as triangles. A 
dotted line represents the limit of detection. Data shown from a single experiment. 
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Figure 2.2. Bacterial loads in C57Bl/6J mice infected subcutaneously with 
either wild type or pGEN-luxCDABE-carrying Y. pestis.  
Animals were infected with ~200 CFU at a cervical site. Organs were harvested 
and plated for bacterial counts at the indicated hours post inoculation.  Bacterial 
numbers are reported in CFU/g of tissue.  Gray and white symbols represent 
organs from animals infected with Y. pestis and Y. pestis carrying pGEN-
luxCDABE, respectively. Each mark represents a value from a single organ and the 
horizontal lines represent the median of the group.  Superficial cervical lymph 
nodes are represented as circles, spleens as squares, and lungs as triangles. A 
dotted line represents the limit of detection and an x letter represents missing 
values of a specific tissue due to the death of an animal. Data shown from a single 
experiment. 
  
24 48 72 96 
hours post inoculation (hpi) 
55 
	  
 
A 
 
B 
            
 
 
 
 6 hpi 
 24 hpi 
 0 hpi 
 6 hpi 
 24 hpi 
 48 hpi 
 72 hpi 
 96 hpi 
 72 hpi. Min = 1.20e4 Max = 2.78e6 
 96 hpi. Min = 9.90e4 Max = 1.01e7 
56 
	  
C 
 
Figure 2.3. BLI of C57BL/6J mice infected subcutaneously with Yplux+ at a 
cervical site.  
(A) Animals were inoculated with ~200 CFU and imaged at the indicated hours post 
inoculation (hpi). Luminescence signal is reported as radiance (p/sec/cm2/sr) in a 
scale paired with a color bar shown next to the images. For 6 hpi, the image in the 
window is shown using an individual color scale with radiance of Min = 8.53e3 and 
Max = 3.97e4. (B) Images of the abdomen at 72 and 96 hpi (same mice shown in 
panel A) under an individual radiance scale (Max and Min values are shown). (C) 
Site of inoculation [skin (inner side)], superficial cervical lymph nodes, spleen and 
liver (from one of the mice shown in A) imaged individually after dissection.  
Individual scales of radiance were used due to variability in signal (site of infection 
and liver, Min = 1.57e5 Max = 3.74e6; lymph nodes, Min = 2.10e6 Max = 2.28e8; 
spleen, Min = 1.73e5 Max = 1.38e7). Shown is a representative experiment.  
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Figure 2.4. BLI of B6(Cg)-Tyrc-2J/J mice infected intradermally with Yplux+ in 
the ear pinna.  
(A) Mice were inoculated with ~200 CFU and were imaged (ventral and dorsal 
sides) at the indicated hours post inoculation (hpi). Luminescence signal is 
reported as radiance (p/sec/cm2/sr) in a scale paired with a color bar shown next to 
the images. For 24 hpi (dorsal view), the window shows an image with signal at an 
individual radiance color scale with of Min = 1.11e4     and Max = 1.43e5.  (B) Site 
of infection (right ear), superficial parotid right and left lymph nodes, spleen and 
liver  (from one of the mice shown in A) imaged individually after dissection.  An 
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 48 hpi 
 72 hpi 
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dorsal ventral 
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*
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asterisk denotes the LN that drains the site of infection. Individual scales of 
radiance were used due to variability in signal (site of infection, Min = 1.89e4 Max = 
8.97e4; lymph nodes, Min = 1.89e6 Max = 8.97e7; spleen and liver, Min = 5.25e5 
Max = 2.34e7).  Shown is a representative experiment. 
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Figure 2.5. BLI after Yplux+ intranasal inoculation in the left nostril of B6(Cg)-
Tyrc-2J/J mice.  
(A) Mice were inoculated IN with ~104 CFU. Images of the neck and head (dorsal 
and ventral) at 24 hpi under an individual radiance scale. The color bars serve as 
reference for radiance intensity (p/sec/cm2/sr; Min and Max values are shown) from 
each spot in the mouse from which signal was detected. (B) Images of the dorsal 
and ventral sides of the animals at different time points (shown in hpi). (C) Signal 
from the lungs after dissection in an animal infected ID in comparison to an animal 
infected IN (Min = 5.02e7 and Max = 8.62e8). (D) Isolated lungs showing a necrotic 
spot (photograph) and how highest levels of radiance (photograph + luminescence) 
originated from this spot (Min = 4.42e6 and Max = 7.02e8).  Color bars serve as 
reference for radiance values.  Shown is a representative experiment. 
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Figure 2.6. BLI of C57BL/6J mice infected subcutaneously with Δcaf1ΔpsaA 
Y. pestis carrying the pGEN-luxCDABE vector.  
(A) Mice were inoculated with ~200 CFU of the double mutant. Images correspond 
to infected animals at different time points post inoculation (shown in hpi).  A color 
bar serves as a reference for the radiance scale (p/sec/cm2/sr) used to standardize 
all images. (B) Images of superficial cervical lymph nodes, spleen and liver (from 
one of the mice shown in A) imaged individually after dissection.  Luminescence 
was detected only from lymph nodes, imaged in an individual scale of radiance with 
a Min = 2.28e6 and Max = 4.27e7. (C) Transformed values (ln) of the mean 
radiance per group from the neck (left) and abdomen (right) from animals infected 
with Yplux+ (gray circles) and YpΔcaf1ΔpsaA lux+ (white circles), as determined by 
measurements from regions of interest (ROI) of images from two independent 
experiments. A dotted line depicts background radiance levels.  Asterisks denote 
statistical significance in differences between the two means compared in a time 
point, as determined by linear regression analysis of transformed values (*, P < 
0.05; **, P < 0.005; ***, P < 0.0005). Error bars represent the standard error of the 
mean (SEM). Shown is a representative experiment. 
 
abdomen neck 
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CHAPTER 3:  BOTTLENECK FORMATION AND HOST EFFORTS                                                          
TO CONTROL BUBONIC PLAGUE 
 
3.1. Overview 
Introduction:  Host-pathogen interactions are complex and difficult to study 
because biologically relevant observations can be made only if all the components 
of infection are taken into account. We studied host-pathogen interactions in vivo 
during dissemination of the causative agent of bubonic plague, Yersinia pestis. 
Methods: We used an intradermal murine model of bubonic plague and assess the 
presence of bottlenecks during dissemination. Oligonucleotide-tagged Y. pestis 
were inoculated in the dermis and tracked to different organs throughout infection. 
In addition, we used confocal microscopy to study bacterial interactions with the 
host at a cellular level during different stages of infection. Moreover, cell depletions 
were used to determine if neutrophils play a role during infection.  
Results: Only a fraction of the tagged strains that were inoculated survived in the 
lymph nodes and in spleens. The majority of the strains were found in the dermis 
throughout infection. After depletion of neutrophils, bacterial numbers were 
significantly higher in the skin in comparison with mice whose neutrophils were not 
depleted. Neutrophils, platelets, and bacteria appeared to interact in blood vessels 
during systemic stages.  
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Conclusions: We identified a bottleneck that restricts bacterial trafficking from the 
skin to the draining lymph node and defines the population that colonizes the host. 
We also found that neutrophils likely restrict colonization of the skin. 
3.2. Introduction 
Most pathogens disseminate from the initial site of contact with the host (site 
of inoculation, SI) to distant tissues. Dissemination allows a pathogen to reach sites 
where nutrients are more abundant or the probability of being transmitted to other 
hosts is higher. A pathogen uses an intricate arsenal to invade new tissues, to 
which the host responds by eliciting immune responses in an effort to eliminate 
infection. The battle between pathogen survival/dissemination and the host 
immune response is critical in defining the outcome of infection and the severity of 
disease. Thus, determining how host and pathogen interact during infection is key 
to understanding disease and to design strategies to control it. For most infectious 
diseases, however, there is a lack of in-depth knowledge about host-pathogen 
interactions in vivo. 
A particularly challenging question is whether dissemination of highly virulent 
pathogens is affected by immune responses. If so, a second challenge is 
understanding when and where these barriers occur. A bottleneck is an example of 
such a barrier, as it restricts the number of individual pathogenic clones that can 
traffic to or colonize a tissue. Bottlenecks have only recently been explored in 
animal models but have been reported in viral (Lancaster and Pfeiffer, 2010), 
parasitic (Mackinnon et al., 2005; Oberle et al., 2010), and bacterial (Lowe et al., 
2013; Melton-Witt et al., 2012; Plaut et al., 2012; Troy et al., 2013) infections. The 
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identification and characterization of bottlenecks is remarkably relevant because 
they (a) mark a stage of infection when an immune response is elicited and when a 
pathogen is susceptible to it, and (b) provide valuable information regarding the 
order in which tissues are colonized through dissemination, and (c) can potentially 
define the final pathogen population that will be transmitted to a new host. This 
latter point has major implications for pathogen evolution. 
Yersinia pestis is the causative agent of bubonic plague, a severe bacterial 
disease characterized by aggressive dissemination within the host and that can be 
lethal if untreated. The bacteria first disseminate from the SI into the draining lymph 
node (LN) after inoculation in the skin (Sebbane et al., 2005). Colonization of LNs 
is then followed by bacterial escape into the bloodstream, resulting in septic shock 
and death (Brubaker, 2006). The ability of Y. pestis to disseminate at high rates 
makes it an unparalleled model to study bacterial dissemination in vivo and to 
understand how the host responds to the threat of severe infection. Successful 
colonization of the host depends on the expression of bacterial virulence factors 
(e.g. type III secretion system, pH6 antigen, F1 antigen) that are upregulated at 
37°C and prevent phagocytosis (Brubaker, 2006; Prentice and Rahalison, 2007; 
Trosky et al., 2008; Zhou et al., 2006)These antiphagocytic factors are predicted to 
be expressed at low levels during the first hours of infection, a notion that gave rise 
to the hypothesis that an intracellular stage facilitates transport from skin to LN 
(Pujol and Bliska, 2005; Titball et al., 2003). This is partially supported by in vitro 
experiments showing bacterial survival in macrophages (Pujol and Bliska, 2003). 
However, recent studies report that in vivo, neutrophils might be the most relevant 
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lineage of cells that interacts with Y. pestis upon inoculation (Bosio et al., 2012; 
Shannon et al., 2013).  
Neutrophils are prominent components of the immune response and are well 
known for their role in controlling infection at multiple levels (Appelberg, 2007; 
Kobayashi et al., 2005; McDonald et al., 2012). As with most studies addressing 
bubonic plague, many reports describing Y. pestis interactions with neutrophils 
have been conducted in vitro and/or with attenuated bacterial strains. For this 
reason, questions such as whether neutrophils play a role during infection have 
been difficult to answer.  
The goal of this study was to identify the major events that occur during 
bubonic plague and the key mechanisms that define the outcome of infection. 
Moreover, we aimed to obtain a high-resolution picture of the host-pathogen 
interactions that take place after inoculation of Y. pestis into the skin of mice. We 
used tagged, virulent Y. pestis to address the presence of bottlenecks during 
dissemination and confocal microscopy to track the bacterium during 
dissemination.  
3.3. Methods  
3.3.1. Bacterial strains and culture conditions. 
Fully virulent Y. pestis CO92 (Parkhill et al., 2001) was used in all 
experiments. For the DA Y. pestis was tagged with 10 variants of an 
oligonucleotide signature tag (Walters et al., 2012). The oligonucleotide tag, along 
with a kanamycin resistance cassette, was inserted at the Tn7 att site in the 
bacterial chromosome (Choi et al., 2005). Each tag contains a unique sequence of 
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~80 bp flanked by invariant sequences that were used for amplification. The10 
tagged Y. pestis CO92 strains were tested in our animal models to ensure each 
had retained the same virulence characteristics of the parent strain. For the DA 
tagged strains were cultured in brain and heart infusion broth (BHI, BD 
Biosciences, Bedford MA) with kanamycin and incubated at 26°C unless otherwise 
stated. Standardized liquid cultures (based on optical density at 600 nm) were 
mixed in a single tube and the mix was serial diluted in phosphate buffer solution 
(PBS) to obtain the desired inoculum. Methods for detection of the tagged strains 
are described in supplemental experimental procedures. For the double inoculation 
experiments, the carbenicillin resistant strain also expressed rfp (for easy 
detection). A mix of the tagged strains was used as the kanamycin resistant strain. 
For the experiments with bacteria grown at 37°C, liquid cultures were grown in BHI 
with 2.5 mM CaCl2 for 6 h at 26°C and then shifted to 37°C for 12.5 h  (Lathem et 
al., 2005). Where needed, kanamycin was added at 25 µg/ml and carbenicillin at 
100 µg/ml. 
3.3.2. Animal infections. 
Six-to-eight week-old female C57BL/6J mice (Jackson Laboratory, Bar Harbor, 
ME) were inoculated under anesthesia (ketamine/xylazine). ID inoculations were 
done in the dorsal side of the ear pinna or the upper side of the foot. A volume of 2 
µL was inoculated with the aid of a Pump11 Elite syringe pump (Harvard 
Apparatus, Holliston, MA) and a SURFLO winged infusion set with a 27-gauge 
needle (Terumo, Lakewood, CO). Animals were sacrificed by injection with sodium 
pentobarbital. Organs were harvested at different time points and homogenized in 
 
	  
71	  
1xPBS with a bead beater. Homogenates were serial diluted and plated on BHI 
agar and incubated at 26°C for 48 hours to obtain bacterial counts. Mann Whitney 
or Wilcoxon matched pairs signed rank tests were used for statistical analysis, 
establishing statistical significance at p < 0.05 using GraphPad Prism version 4.0c 
(GraphPad Software, La Jolla, CA). All animal studies were approved by the 
University of North Carolina Office of Animal Care and Use, protocol 11-128. For 
experiments with phagocyte depletion see supplemental experimental procedures. 
2.3.3. Whole ear imaging 
Mice were inoculated with gfp- or rfp-expressing Y. pestis (Hoopes et al., 
2012; Price et al., 2012) following the procedures described above. After the mice 
were sacrificed, their ears were separated from the head, gently punctured with 
scissors (to facilitate fixative diffusion), and submerged in 10% buffered formalin for 
24 hours. The dermis of the dorsal leaflet was exposed by separating both leaflets 
and removing the layer of cartilage that separates them. Ears were mounted on 
glass slides with ProLong Gold antifade reagent with 4',6-diamidino-2-phenylindole 
(DAPI; Molecular Probes, Eugene, OR). Neutrophils and platelets were stained by 
tail-vein injection of fluorescently labeled antibodies against Ly6G (BD, Franklin 
Lakes, NJ) and GPIX clone Xia.B4 (Emfret Analytics, Eibelstadt, Germany), 
respectively. Lymphatic vessels were stained by ID injection of fluorescently 
labeled podoplanin antibody clone 8.1.1 (BioLegend, San Diego, CA) and LYVE1 
antibody (Fitzgerald, Acton, MA) (Hoopes et al., 2012; Schindelin et al., 2012). For 
all antibodies, 5 ng of antibody was used per mouse. Images were taken with an 
Olympus FV1000 MPE SIM laser scanning confocal microscope and analyzed with 
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the Fiji software package (Chtanova et al., 2008; Daley et al., 2007; Schindelin et 
al., 2012). The same procedures were used to image LNs and the lymphatic 
vessels that connect ears and LNs. These vessels were also visualized by injection 
of 10% Evan’s blue in the ear.  
3.3.4. Detection of oligonucleotide-tagged strains 
Bacteria that grew on agar plates from undiluted homogenized organs were mixed 
with 1 mL of PBS using a bacterial cell spreader until a homogeneous suspension 
was formed. A volume of 20 µL of this suspension was added to BHI broth with 
kanamycin and incubated at 26°C in a roller drum for 14 h. When less than 15 
colonies were present on a plate, individual colonies were picked with a wooden 
stick and grown under the same conditions described.  DNA was extracted from 
liquid cultures using a Wizard Genomic Purification Kit (Promega, Madison, WI). 
DNA concentrations were measured and standardized at 100 ng/µL.  The 
oligonucleotide tag sequence was amplified by PCR using primers P2 (5’-TAC CTA 
CAA CCT CAA GCT-3’) and P4 (5’-TAC CCA TTC TAA CCA AGC-3’), which 
hybridize to the invariable region of all oligonucleotide tags. PCR reactions were 
prepared under standard conditions except for (a) the use of a mix of 
dideoxynucleotides (ddNTPs) with a ddATP:ddCTP:ddGTP:ddTTP ratio of 5:1:5:5 
and (b) ddCTP labeled with P32 was incorporated into the reaction. PCR reactions 
were cleaned using a MiniElute kit (Promega, Madison, WI). Southern dot blot 
assays were conducted using the obtained amplicon as probe. The probe was 
hybridized to positively charged nylon membranes (Roche, Manheim, Germany) 
with 200 ng of crosslinked plasmid DNA. The DNA crosslinked to the nylon 
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membrane was arranged in 10 separate spots, each one containing DNA of each 
of the unique oligonucleotide tags used in the study. Because 10 of the 
oligonucleotides were used in the membranes and 9 were used to inoculate the 
mice, one of the oligonucleotides spotted on the membranes served as negative 
control.  
3.3.5. Phagocyte depletion 
Ly6G+ cells were depleted after tail vein injection of 100 µL (0.2 mg/mL) of low 
endotoxin Ly6G antibody clone 1A8 (BioLegend, San Diego, CA) (Chtanova et al., 
2008; Daley et al., 2007). Monocytes and monocyte-derived cells were depleted by 
injecting 0.45 mg/mouse of clodronate-encapsulated liposomes (Encapsula Nano 
Sciences, Nashville, TN) (Eidsmo et al., 2009; Kataru et al., 2009; Price et al., 
2012; Ward et al., 2011). Both, Ly6G antibody and clodronate-encapsulated 
liposomes, were injected 24 hours before inoculation of bacteria. Depletion of 
targeted cells was assessed by flow cytometry defining neutrophils as Ly6G+ cells; 
monocytes as F4/80-, CD11b+, Ly6G- cells; macrophages as F4/80+ cells; and 
dendritic cells as F4/80-, CD11b+ cells.  
3.4. Results  
3.4.1. Y. pestis passes through a bottleneck during dissemination to the LN that 
drains the skin 
Conventional approaches to assess dissemination in vivo include quantifying 
bacterial burden in tissues at different time points. We wanted to learn about Y. 
pestis dissemination at a population level by determining whether all the members 
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of the inoculum population could be found beyond the SI. Thus a dissemination 
assay (DA) was developed based on the use of 10 oligonucleotide-tagged Y. pestis 
strains. These strains (hereafter referred to as “tagged strains” or simply “strains”) 
were generated by inserting a unique oligonucleotide tag at a neutral site in the 
bacterial chromosome (Walters et al., 2012). Each tagged strain was tested and 
found to possess the same levels of virulence and growth as un-tagged Y. pestis 
(data not shown). A mix of 9 tagged strains served as the inoculum in a murine 
intradermal (ID) model of infection [the tenth strain (A6) served as a negative 
control]. In this model, ~200 colony forming units (CFU) are injected in the ear 
pinna in a 2 µl volume to avoid confounding effects derived from tissue damage 
caused by larger volumes. DNA extracted from bacteria recovered at desired time 
points post-inoculation was subjected to Southern Blot analysis to determine which 
strains disseminated from the SI. DNA from the inoculum and from un-tagged Y. 
pestis was used as positive and negative controls, respectively. 
At early time points, 12 hours post inoculation (hpi), the number of tagged 
strains in the LN ranged from one to five (average 2.2 Figure 3.1A). At 48 hpi, 
colonization of the LN was well established, systemic dissemination has occurred, 
and mice were close to succumbing to disease. The number of tagged strains 
present in the LN at 48 hpi ranged from one to five (average 2.8, Figure 3.1B). We 
then increased the inoculum 10-fold (~2000 CFU) to test if increasing the numbers 
of each tagged strain (~222 CFU per tagged strain) would alter the number of 
strains reaching the LN. This inoculum far exceeds the reported average inoculated 
in mouse skin by a flea (636 CFU, median 82 CFU) (Lorange et al., 2005). Out of 
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eight mice, four had all 9 tagged strains, one had 8, one had 7, and two had 6 (data 
not shown). Overall, these data indicate Y. pestis passes through a strong 
bottleneck after inoculation into the ear. Our data also suggests this bottleneck 
occurs during the first 12 hours of infection, before systemic dissemination takes 
place.  
3.4.2. The bottleneck defines the population that colonizes the host and is 
abrogated after subcutaneous inoculation 
While it is currently thought that Y. pestis follows a SI-LN-blood route for 
systemic colonization (Gonzalez et al., 2012; Sebbane et al., 2005), it is possible 
that some bacteria escape from the SI directly into blood. We repeated our DA and 
included spleens, an organ used to assess systemic dissemination. All but one 
mouse (n=8) had the exact same strain population in spleens and in LNs (Figure 
3.1C). The mouse that was the exception to this, had strains A3, A4, A5, and B2 in 
the LN but only A5 and B2 in the spleen. Repetitions of this experiment showed the 
same trend: either the exact same strains in both organs (majority of cases), or 
spleens lacking one or more strains that were present in LNs. We have never 
observed a strain present in the spleen that was not present in the LN. This is in 
agreement with the notion of Y. pestis disseminating from SI to LN and then to the 
rest of the body. More importantly, this suggests that the bottleneck defines the 
population that is responsible for systemic colonization of the host and that will be 
(potentially) transmitted to a naïve flea. 
We next wanted to test if the bottleneck was an ear-specific phenomenon or if 
it could be replicated from a different anatomical site. We performed a DA 
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comparing mice inoculated in the ear (superficial parotid LN) with mice inoculated 
in the foot (popliteal LN). A limited number of tagged strains were observed in the 
LN (median of 3) and spleens (median of 2) of mice that were inoculated in the 
foot, indicating that this bottleneck is not an infection-site specific phenomenon 
(data not shown). 
To determine if the dermis influenced the bottleneck, we repeated the DA with 
a subcutaneous (SC) route of infection. We used a well-established SC model that 
has been used extensively in our laboratory, inoculating on the ventral side of the 
neck (Cathelyn et al., 2006). The number of tagged strains in LNs from mice 
inoculated SC increased significantly over those inoculated ID (median value of 
8.5, Figure 3.1D). This suggests the bottleneck can be abrogated if bacteria are 
deposited in a site other than the dermis and that its formation is linked to this 
specific layer of the skin. 
3.4.3. The bacteria that do not pass through the bottleneck are confined to the site 
of inoculation 
We hypothesized that the source of the bottleneck was bacterial killing in the 
ear (SI). If this were true, the population of tagged strains in the ear should match 
that found in the LN. To test this, we performed a DA and compared the tagged 
strains in the ears with the respective LNs at 12 and 48 hpi. As opposed to what 
was observed in LN and spleens, the ear contained a majority of tagged strains, 
ranging from four to nine strains (median of seven and six at 12 and 48 hpi, 
respectively; Figure 3.2A).  These data indicate survival of Y. pestis in the ear and 
formation of bottleneck are separate events. These data also indicate the 
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bottleneck between the SI and draining LN is established early and is maintained 
throughout infection.  
We hypothesized that, after being in the skin for some time, bacteria could 
elicit a change in the microenvironment of the skin, altering their ability to move to 
the LN. To test this, we inoculated mice in the ear with a Y. pestis strain that is 
resistant to carbenicillin (~650 CFU) and, 24 hpi, we inoculated the same animals 
at the exact same spot with a Y. pestis strain that is resistant to kanamycin (~450 
CFU). The inocula were intentionally different to make any effect more evident. LNs 
were harvested 48h after the first inoculation and plated on media with either 
carbenicillin or kanamycin. Bacterial loads in LNs were compared to those from a 
group of mice that were injected with PBS at the first inoculation time. We found 
lower bacterial loads of kanamycin resistant bacteria in LN of mice whose ears 
were previously exposed to bacteria in comparison with those that were exposed to 
PBS (Figure 3.2B). This reduction of bacterial loads could be very pronounced (no 
bacteria in LNs,), or moderate (data not shown) but was always found to be 
statistically significant when compared to the control group. These data indicate 
that the skin develops growth restrictive properties after being exposed to Y. pestis. 
These properties affect the movement of newly inoculated bacteria into the LN. 
3.4.4. Visualization of bacteria at the injection site, LNs, and lymphatic vessels that 
connect both tissues 
Y. pestis survives in multiple tissues during infection. This has been shown 
extensively through experiments where tissues of infected animals are harvested to 
obtain bacterial burdens. However, such an approach makes it impossible to make 
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qualitative observations of direct interactions with the host. We used microscopy to 
study in more detail how Y. pestis interacts with the host during dissemination from 
the ear. After ID inoculation with Y. pestis expressing rfp (RFP-Y. pestis) or gfp 
(GFP-Y. pestis), whole tissues were fixed and imaged using confocal microscopy. 
This approach was chosen as opposed to histological sections to obtain images of 
bacteria in tissues whose architecture was minimally disrupted. To improve 
visualization of bacteria, however, the cartilage was removed to expose the dermal 
layer of the ear pinna after fixation. Bacteria were localized exclusively at two 
specific sites in the ear. One was the injection site, defined by the small and 
transient wheal (bubble) that forms in the skin during inoculation. Bacteria at this 
site were found mostly in large clumps or as small groupings of cells (Figure 3.3A 
and B). The second site where bacteria were found was at the base of the ear in 
the shape of tube like structures, noted at 24 hpi. The presence of these tubes was 
infrequent but when seen, signal was so strong that it could be seen easily at lower 
magnifications without separating the ear leaflets (Figure 3.3C). As opposed to 
blood vessels, which look red under bright field microscopy, the tubes were only 
visible using fluorescence microscopy (Figure 3.3D). Bacteria were distributed 
unevenly in these tubes and appeared as individual or very tight clumps of bacteria 
(Figure 3.3 E, F, and G). Staining with DAPI revealed the presence of host cells in 
very close proximity to bacteria inside of these tubes (Figure 3.3H).  
To determine if bacteria could be detected in the lymphatic vessels that 
connect ear and LN, we removed and fixed the infected ear pinna along with as 
much adjacent tissue as possible up to the cervical region (Figure 3.4A), including 
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the draining LN and the lymphatic vessels that connect both tissues. In LNs at 24 
hpi, Y. pestis appeared to be in discrete microcolonies and inside afferent 
lymphatic vessels (Figure 3.4Ai, Aii, and Aiii). At 48 hpi, very strong signal was 
detected from these sites (Figure 3.4B). Bacteria inside the afferent lymphatic 
vessels were found either as single cells and small groups or formed tight clumps 
(Figure 3.4C, D, and E). There also were numerous bacterial associations with host 
cells, as revealed by DAPI stain (Figure 3.4F). Lastly, bacteria were detected in the 
lymphatic vessels that connect the LN and the ear pinna (Figure 3.4G, H, I, and J). 
These data provide direct evidence that Y. pestis travels to the lymph node in the 
lymphatic vessels rather than through blood.  These data also indicate for the first 
time that many bacteria in the lymphatics are not associated with host cells. 
3.4.5. Neutrophils control Y. pestis expansion in the dermis. 
To gain insights into what role neutrophils play during infection, we tracked 
these cells by microscopy imaging. Because our model of infection causes very 
little disruption to the dermis, observations of the skin at very high resolution and 
with high levels of accuracy can be made. We used fluorescently labeled anti-
Ly6G, an antibody that binds to neutrophils (Daley et al., 2007) to track these cells 
during infection. At 30 minutes post inoculation, very few isolated clusters of 
neutrophils were observed in the skin, and none were associated with Y. pestis 
(Figure 3.5A). Between 4 and 8 hpi, many bacteria were in close proximity to 
neutrophils or inside them (as determined by confocal microscopy). At 24 hpi a 
prominent increase in neutrophils was observed in comparison to previous time 
points. Neutrophils were highly concentrated at the injection site, forming very 
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dense clusters. However, very few bacteria seemed to be associated with 
neutrophils at this time point. Similar to previous time points, neutrophils were 
present in vascular tissue at very low numbers/densities. At 48 hpi, systemic 
infection was evidenced by bacteria observed inside blood vessels. In the vascular 
tissue, large numbers of neutrophils were observed, and bacteria were associated 
with some neutrophils. These neutrophils with associated bacteria appeared to be 
circulating (one or two bacteria with very few neutrophils, (Figure 3.5B, 48 hpi, i), or 
in tight aggregates that localized to the walls of blood vessels, filling the entire 
lumen of the vessel in some instances (Figure 3.5B, 48 hpi, ii). Staining with 
fluorescently labeled anti-GPIX, an antibody that binds to platelets, revealed 
clusters of neutrophils that appeared to be connected by platelets. This was 
especially true for the tight neutrophil aggregates that localized to the walls of the 
blood vessels (Figure 3.5B, 48 hpi, iii). We collected ears from mice that were 
found dead (0-12 hours after death) in hopes of seeing what infection looked like at 
the moment of death. These images revealed a striking increase in bacterial 
numbers in blood vessels, with dense bacterial clusters localized to the walls of 
blood vessels and filled capillaries. Some vessels had a “bacterial plug” surrounded 
by neutrophils that stretched across the transversal plane of the vessel (Figure 
3.5B, mouse found dead, iii-vi).  
Bacterial numbers in the skin at the injection site did not seem to increase over 
time, but did not decrease either. We hypothesized that neutrophils control 
bacterial burden in the skin, but are unable to clear the infection. We and others 
have speculated that neutrophils could have an effect on bacterial trafficking to LNs 
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(Shannon et al., 2013) and bottleneck formation. Depletion of neutrophils using the 
Ly6G antibody had no impact on bacterial trafficking (Figure 3.6A) or bottleneck 
formation as determined using the DA (data not shown), indicating that neutrophils 
do not contribute to these processes. However, mice depleted for neutrophils 
showed a highly significant increase in the number of bacteria in the skin (ear) 
compared to mock treated mice (Figure 3.6B). In addition, nearly all anti-Ly6G-
treated mice retained all nine tagged strains at the SI (data not shown). We noted 
that an increase in bacterial burden at the SI only occurs in the absence of 
neutrophils. Because this observation conflicts with previous reports describing 
bacterial growth in the ear (Bosio et al., 2012; Guinet and Carniel, 2003; Shannon 
et al., 2013), we speculated that differences in the ID models of infection could 
contribute to these divergent results. In our model, a 2 µl volume is used to deliver 
the inoculum, whereas others have used 10 µl (Belkaid et al., 1998; Gonzalez et 
al., 2012; Guinet and Carniel, 2003; Lin et al., 2012; Shannon et al., 2013; 
Thackray and Field, 2000). We compared bacterial burden in the ear of mice after 
inoculation of 2 and 10 µL, keeping the inoculum CFU constant for both groups. 
Mice inoculated with the larger volume showed a statistically significant increase in 
the number of bacteria recovered from the ear in comparison with mice inoculated 
with the smaller volume (data not shown). Overall, these experiments suggest Y. 
pestis interacts with neutrophils in the dermis and that these interactions restrict 
colonization of the skin. In addition, these data show that bacteria that circulate 
systemically interact with neutrophils and other cell types such as platelets. 
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3.4.6. Dissemination of Y. pestis with the flow of lymph 
It has been suggested that for Y. pestis to move into LNs, an intracellular 
stage must exist (Pujol and Bliska, 2005; Titball et al., 2003). Results presented 
here and another recent study (Shannon et al., 2013), suggest neutrophils are not 
important for bacterial movement to LN. Shannon, et al. also concluded that the 
interactions of Y. pestis with dendritic cells in vivo are minimal and unlikely to be 
significant for bacterial dissemination. To gain insight on how Y. pestis travels to 
draining LNs, we explored the notion that it could be transported by the flow of 
lymph as opposed to being associated with phagocytes. In vivo models of bubonic 
plague infections use Y. pestis grown at 26°C, the temperature consistent with 
delivery from a flea. At 26°C, the antiphagocytic factors that are crucial for Y. pestis 
survival in the host are predicted to be weakly expressed. Studies with cell lines 
and primary cells found that Y. pestis is significantly less susceptible to 
phagocytosis by macrophages, dendritic cells, and to a lesser extent by 
neutrophils, when grown at 37°C than when grown at 26°C (Charnetzky and 
Shuford, 1985; Spinner et al., 2008; 2013; Zhang et al., 2008). Because it has been 
predicted that Y. pestis travels from the skin to LNs inside of phagocytes, we 
hypothesized that bacteria grown at 37°C would not disseminate efficiently to LNs. 
Surprisingly, we found that mice inoculated with comparable numbers of bacteria 
grown either at 26°C or 37°C showed no difference in bacterial loads in LNs, 
spleens, or ears (Figure 3.7). These data suggest that association with phagocytes 
might not be necessary for Y. pestis to disseminate from the skin to the draining 
LN. 
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3.5. Discussion  
Pathogen dissemination in the host is a crucial and understudied process of 
infection. Although many studies have addressed bacterial-host interactions of Y. 
pestis (and other highly virulent pathogens), most of them are limited by the use of 
in vitro approaches and/or the use of attenuated strains. While many noteworthy 
observations have derived from these studies, we believe that a complete picture 
of infection can only be achieved by using fully virulent strains in an in vivo context. 
Herein, we looked at dissemination of fully virulent Y. pestis in mice. We used (1) 
an ID model of infection with minimal disruption to the skin, (2) an assay (DA) that 
allowed us to follow dissemination at a population level, and (3) microscopic 
imaging of the skin and underlying tissue to observe host-pathogen interactions at 
a cellular level. The combination of these strategies gave us a high-resolution 
picture of infection that allowed us to make biologically relevant observations of a 
bacterial-host system.  
Upon ID injection, the dissemination assay revealed that a bottleneck 
accounts for a previously unrecognized barrier for Y. pestis dissemination from the 
SI. The bottleneck has strong evolutionary implications for Y. pestis. This is 
because it defines the population of bacteria that have the potential to be acquired 
by a naïve flea and thus be transmitted to a new host. Interestingly, the bottleneck 
is abrogated when bacteria are delivered in the SC space beyond the dermis. This 
is relevant, as it is very likely that fleas deliver Y. pestis into the dermis and not the 
SC space (Hinnebusch, 2005; Sebbane et al., 2006). The dermis is particularly 
proficient in triggering immune responses against invaders. Differences in 
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immunogenicity between layers of the skin have also been shown to exist in cancer 
research. Adenocarcinoma cells in rats develop into tumors only after SC but not 
ID injections (Bonnotte et al., 2003). The SC layer of the skin, on the other hand, is 
less immunologically competent and this might facilitate the passage of more 
tagged strains into the LN (Combadiere and Liard, 2011). This might occur due to 
delayed influx of immune cells from blood therefor allowing for more local bacterial 
replication prior to dissemination. Our research is currently focusing on what is 
unique in the dermis that makes it an optimal site for bottleneck formation. We 
propose that the bottleneck originates from multiple factors that work in an additive 
manner and that derive from both the pathogen and host. We found that factors 
that we hypothesized affect bacterial movement to LNs such as injection volume 
play no role in bottleneck formation.  Preliminary studies testing the role of other 
potential factors in bottleneck formation (iNOS, coagulation, mast cells) indicate 
these factors have no effect either (unpublished results).  
Even under conditions when most mice succumb to plague, bottleneck 
formation could be highly efficient in some individuals. Nearly 10% of our mice 
showed no bacteria in the LN. This was not due to ineffective inoculation as we 
confirmed that 100% of the mice had bacteria in the inoculated ear. This suggests 
that efficient bottlenecks form in a fraction of more immunocompetent individuals, 
perhaps as a result of inherent variability in the immune responses of a population. 
It is not known how the immune response varies during a natural flea inoculation 
(vs. needle inoculation) and how this would affect bottleneck formation. However, 
in Leishmania major infections, more robust and prevalent infiltration of neutrophils 
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is observed during sand fly versus needle inoculations (Peters et al., 2009). If a Y. 
pestis inoculating fleabite also results in augmented immune responses, one would 
expect that the rate of successful infections from fleabites would be low, due to the 
bottleneck. In agreement with this, studies using fleas have estimated the rate of 
successful plague infections in mice by fleabites to be less than 50% (Lorange et 
al., 2005).  
Very few studies have used imaging to probe host-pathogen interactions 
during cutaneous infections in vivo (Chong et al., 2013). We used an ID model with 
little disruption to the dermis and fluorescence confocal microscopy of unsectioned 
tissues to track Y. pestis throughout infection. This provided us with high-resolution 
observations to reveal bacterial localization and associations in the host without 
requiring the use of attenuated strains. Microscopy imaging provides qualitative 
information to understand interactions with the host that is impossible to collect by 
traditional approaches using bacterial counts from harvested organs. The use of 
microscopy imaging, in combination with the use of depleting antibodies, allowed 
us to reveal a role of neutrophils during infection of the dermis. Recent research 
suggested bacteria could evade a strong neutrophil response in the skin (Bosio et 
al., 2012; Shannon et al., 2013). Our observations are in agreement with these 
reports, as we did not observe bacterial clearance in the skin. However, we also 
found that neutrophils severely restrict bacterial colonization of the skin, and thus, 
established a function for neutrophils in vivo. The bacterial restrictive properties of 
the skin (largely driven by neutrophils) are likely to be absent at the onset of 
infection. However, once present, they affect the bacteria in the skin in such a way 
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that movement of newly inoculated bacteria into LNs is restricted, as shown by our 
double inoculation experiment. Altering the skin environment by injecting higher 
volumes appears to abrogate these restrictive properties of the dermis. Higher 
volumes might “dilute” components of the initial immune response in the dermis, 
preventing direct contact of bacteria with neutrophils, or delaying detection of 
bacteria.  
 In addition to the role played by neutrophils, we also found numerous platelet 
associations with these cells during systemic infection. Platelets associate with 
neutrophils during sepsis and play a role in the formation of neutrophil extracellular 
traps (NETs) (McDonald et al., 2012). Although it has been suggested that Y. 
pestis inhibits platelet aggregation (Leung et al., 1990), we observed robust 
accumulation of these cells associated with neutrophils in blood vessels. Whether 
the platelet-neutrophil associations we observed result in efficient formation of 
NETs or affect disease progression in any way is unknown.  
How pathogens disseminate from the SI into deeper tissues is one of the most 
relevant questions in microbial pathogenesis and one that is very difficult to 
address using direct approaches. For many pathogens, including Y. pestis, an 
intracellular stage to reach distant tissues has been proposed (Pujol and Bliska, 
2005; Titball et al., 2003). In this study, our data suggest that association with host 
cells does might not be necessary for Y. pestis to travel to LNs. Similar claims have 
been made for the highly virulent pathogen Bacillus anthracis (Weiner and 
Glomski, 2012) and for Salmonella abortusovis. In the latter case, 80% of the 
bacteria traveling to LN were found to be free in lymphatic vessels during the first 
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90 minutes of infection (Bonneau et al., 2006). While our data suggest Y. pestis 
flows freely in lymph fluid, we cannot discard the possibility that bacteria travel to 
LNs in multiple ways. Movement with the flow of lymph (free bacteria) and 
trafficking with host cells (intracellularly or attached to their surface) might occur 
simultaneously.   
In conclusion, our observations suggest that upon inoculation most bacteria 
remain in the skin and few escape to lymphatic vessels, in part carried along by the 
flow of lymph. For the bacteria that remain in the skin, an equilibrium state 
develops where bacteria are neither cleared nor able to proliferate. These bacteria 
have no means to move to the LN and do not contribute to disease. By the time 
these processes occur, the few bacteria that escaped via lymphatic vessels have 
likely already reached the LN, and subsequently move into blood vessels. 
Expression of specific genes might be necessary for Y. pestis to adapt to these 
very different immunological environments, where new threats (such as NETs) are 
encountered. Most likely, however, once in the lymph node, Y. pestis is favored 
over the host and the outcome of infection is already defined. 
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3.6. Figures and Tables 
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Figure 3.1. A bottleneck limits dissemination of Y. pestis to the draining LN.  
(A and B) Southern dot blot analysis of DNA from bacteria from LNs harvested at 
12 hpi (A) and 48 hpi (B). Each row shows results from a single mouse (identified 
with a number). The number of CFU obtained from each tissue and from which 
DNA was extracted is also shown (CFU). (C) Southern dot blot analysis of DNA 
from bacteria from LNs and spleens belonging to the same mouse and harvested 
at 48 hpi. Each row shows results from a single mouse (identified with a number). 
“no bacteria present” identifies mice whose LN or spleen had no detectable 
bacteria. All mice had comparable numbers of bacteria in the ear (including the 
ones with negative LNs, not shown). The number of tagged strains present in each 
LN is also shown. At least 10 experiments were done and the blots shown belong 
to one representative experiment. (D) The number of tagged strains were 
quantified in LNs at 48 hpi of mice inoculated ID in the ear pinna (black circles) or 
subcutaneously (white circles) in the ventral side of the neck. Differences between 
groups were determined by the Mann-Whitney test and statistical significance was 
established at p < 0.05. Data from two combined experiments are shown. Each 
circle represents the number of tagged strains obtained from LNs from a single 
mouse. Horizontal bars represent the median value of the group. 
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Figure 3.2. Bacteria that do not pass through the bottleneck are confined to 
the site of inoculation.  
(A) Mice were inoculated ID in the ear pinna with ten tagged strains of Y. pestis. 
The number of tagged strains present in ears (triangles) and LNs (circles) at 12 hpi 
(black symbols) and 48 hpi (white symbols) is shown. Combined data from two 
independent experiments are shown. Differences between groups were determined 
by Wilcoxon matched pairs signed rank test, establishing statistical significance at 
p < 0.05. (B) Bacterial burden from LNs after two consecutive inoculations. Mice 
were inoculated with carbenicillin resistant Y. pestis (Y. pestis, carb) and, 24 hours 
after, were inoculated again at the same spot in the ear with kanamycin resistant Y. 
pestis (Y. pestis, kan). Another group of mice was mock inoculated with PBS and, 
24 hours after, inoculated with kanamycin resistant Y. pestis (PBS, kan). The 
dotted line represents the limit of detection (values of one or zero CFU/plate are 
considered to be at the limit of detection). The experiment was repeated three 
times under similar conditions. Data from one representative experiment are 
shown. The experiment was repeated under similar conditions two more times. 
Differences between groups were determined by the Mann-Whitney test and 
statistical significance was established at p < 0.05. Each symbol (triangle or circle) 
represents the number of tagged strains (A) or CFU (B) obtained from a tissue from 
a single mouse. Horizontal bars represent the median value of the group. 
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Figure 3.3. Bacteria are visualized at the injection site and in tubes at the 
base of the ear pinna.  
GFP or RFP-Y. pestis were inoculated ID in the ear pinna and this tissue was 
imaged using confocal microscopy to determine bacterial distribution in this tissue. 
(A and B) RFP-Y. pestis in clumps (A) or small groups (B) at the injection site 
minutes after inoculation. (C-G) GFP-Y. pestis in tubes located at the base of the 
ear (C). The tubes are not blood vessels (arrowhead), as the latter appear dark red 
under bright field microscopy (D). (E-G) Bacteria are in these tubes are dispersed 
(F) or in tight aggregates (G). (H) RFP-Y. pestis are associated with host cells 
inside of the tubes. Except for C and D (taken with a dissecting stereomicroscope), 
the images show maximum intensity projections from z-stacks. The white bar is 
shown as reference for scale. 
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Figure 3.4. Bacteria are visualized in LNs and in the lymphatic vessels that 
connect these compartments with the ear.  
 
	  
93	  
Mice were inoculated with RFP-Y. pestis and the ear pinna was removed along 
with surrounding tissue, including draining LNs. (A and B) Ears were injected with 
fluorescently labeled podoplanin and LYVE-1 antibody (red) and tissues were 
removed at 24 (A) and 48 (B) hpi. Site of injection (asterisk), ear canal, and LN are 
shown. LNs show few microcolonies (green) at 24 hpi (Aii shows the LN in Ai at 
higher magnification). An afferent tube connected to LN is shown (Aiii). In the same 
panel, two sections of an afferent tube (red) with bacteria (green) are shown. 
Tissues removed at 48 hpi show strong signal from LN (B). Bii shows the LN in Bi 
at higher magnification. Lymphatic vessels (arrowheads) attached to LN and filled 
with bacteria (green) are shown in Bii and Biii. (C-D) Lymphatic vessels attached to 
LNs with dissociated bacteria (red) or bacteria arranged in clumps (C and D). 
Section of a lymphatic vessel with bacteria arranged with their long axis running 
along the long axis of the tube (E). Bacteria associated with host cells inside 
lymphatic vessels (F). (G-J) Bacteria (green) in tubes (arrowhead, I and J) in the 
space in between the ear and LN. In A, B, and H-J, bacteria were false-colored. 
The white bar is shown as reference for scale. 
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Figure 3.5. Bacterial interactions with neutrophils throughout infection.  
Mice were inoculated ID in the ear pinna with RFP-Y. pestis prior to intravenous 
injection with fluorescently labeled Ly6G antibody to visualize neutrophils (green). 
Ears were removed for confocal microscopy imaging. Diagrams of the major 
observations per time point (from a representative ear) are shown (left). Blood from 
injection is represented with a pink irregular mark, bacteria as small red rods, 
neutrophils as green blebs with a blue nuclei, and platelets as small cyan circles. At 
least four ears per time point were analyzed to determine the major observations 
that are reported. The images show maximum intensity projections from z-stacks. 
The scale bar represents 10 µm. 
(A) Ears were removed before systemic dissemination at 0.5, 7 and 24 hpi and the 
site of injection was imaged. For 0.5 hpi, i and ii, illustrate clouds of neutrophils and 
iii illustrates isolated bacteria. For 7 hpi, i, and ii, illustrate bacteria distant and close 
to neutrophils. iii illustrates bacteria inside of a neutrophil. For 24 hpi, i illustrates 
dense aggregates of neutrophils in the skin; ii illustrates bacteria in close proximity 
to neutrophil aggregates; iii illustrates neutrophils in blood vessels in the injection 
site.  
(B) Ears were removed after systemic dissemination at 48 hpi and from mice that 
were found dead. Images shown belong to blood vessels outside the injection site. 
For 48 hpi, i illustrates bacterial associations with neutrophils and platelets (stained 
with fluorescently labeled GPIX, false-colored cyan); ii illustrates neutrophil 
aggregates filling the lumen of a blood vessel; iii illustrate large aggregates of 
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neutrophils with platelets in association with bacteria and localized to the wall of a 
blood vessel. For the mouse found dead i and ii illustrate bacteria in a large blood 
vessel and a capillary, respectively; iii illustrates a blood vessel with a “bacterial 
plug”; a similar vessel is illustrated in iv and neutrophils covering the plug are 
shown in v; vi shows an overlay of iv and v.  
          
Figure 3.6. Y. pestis colonization of the skin is restricted by neutrophils.  
Mice were injected intravenously with PBS (black symbols) or with an antibody 
(Ly6G) that depletes neutrophils (white symbols). At 12 hours after ID inoculation of 
Y. pestis in the ear pinna, LNs (A, circles) and ears (B, triangles) were harvested, 
homogenized and plated to obtain bacterial counts. Each symbol (triangle or circle) 
represents the number of CFU obtained from a tissue from a single mouse. 
Horizontal bars represent the median value of the group. The dotted line 
represents the limit of detection (values of one or zero CFU/plate are considered to 
be at the limit of detection). All values obtained from ears were higher than the limit 
of detection. The experiment was repeated two times under similar conditions. 
Data from one representative experiment are shown. Differences between groups 
were determined by the Mann-Whitney test and statistical significance was 
established at p < 0.05.  
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Figure 3.7. Bacterial dissemination from the ear to the draining LN.  
Mice were inoculated ID in the ear pinna with Y. pestis grown at 26°C (black 
symbols) or 37°C (white symbols) and colony forming units (CFU) per tissue from 
lymph nodes (circles), spleens (squares), and ears (triangles) were harvested at 48 
hpi. Each symbol (circle, square, or triangle) represents the number of CFU 
obtained from a tissue from a single mouse. Horizontal bars represent the median 
value of the group. The dotted line represents the limit of detection (values of one 
or zero CFU/plate are considered to be at the limit of detection). The experiment 
was repeated two times. Data from one representative experiment are shown. 
Differences between groups were determined by the Mann-Whitney test and 
statistical significance was established at p < 0.05.  
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CHAPTER 4: AN INTRADERMAL ROUTE OF BUBONIC PLAGUE REVEALS 
UNIQUE PATHOGEN ADAPTATIONS TO THE DERMIS 
 
4.1. Overview 
Introduction: Arthropods transmitting infectious diseases most likely inoculate 
pathogens in the dermis of mammals. Despite this, subcutaneous models of 
infection are broadly used in many fields, including Yersinia pestis pathogenesis.  
We compared an intradermal with a subcutaneous model of Y. pestis during 
bubonic plague in mice to determine if the route of inoculation affects disease 
progression. 
Methods: We inoculated mice using each route, assessed survival, and obtained 
bacterial burden in different tissues to assess the kinetics of infection. In addition, 
attenuation of a deletion mutant of yapH was tested to determine phenotype 
changes with each model. 
Results: We found that the size of the inoculum influenced mouse survival after 
intradermal inoculation but not after subcutaneous inoculation. In addition, 
intradermal inoculation resulted in faster kinetics of infection. Moreover, the yapH 
deletion mutant we tested was attenuated in the intradermal but not subcutaneous 
model of infection. 
Conclusions: Our data indicate that the more biologically relevant intradermal 
model of bubonic plague shows important differences in multiple aspects of 
infection when compared with a subcutaneous model. We believe our findings 
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might have important implications for the study of vector-borne pathogens, skin 
immunology, and vaccine development. 
4.2. Introduction 
As a pathogen disseminates inside a host, it must travel through multiple 
tissues to reach distant sites. These tissues are in themselves microenvironments 
with defined immunological characteristics that serve as barriers to prevent spread. 
Epithelial tissues, such as the skin, are the first barriers an invader has to break in 
order to penetrate into deeper organs. The skin epithelium is an active immune site 
that can elicit an effective immune response against many invaders. However, 
some pathogens can overcome these immune responses and are able to 
disseminate to deeper tissues and cause disease.  
Based on its histological architecture, the skin can be divided into three main 
layers: epidermis, dermis, and subcutaneous space (also known as hypodermis) 
(Teunissen et al., 2012). Each layer encompasses unique immunological 
characteristics that we are just beginning to understand (Nestle et al., 2009). The 
epidermis is the outermost layer and constitutes a physical barrier that pathogens 
must cross to enter the body. This barrier can be surpassed by the mechanical 
action of a bite from a blood feeding arthropod (Frischknecht, 2007). Arthropods 
that carry a pathogen and that can actively transmit it to a host are termed vectors.  
The dermis is generally the starting site for natural infections with vector-borne 
pathogens (Belkaid et al., 1998; Chong et al., 2013; Choumet et al., 2012; 
Sebbane et al., 2006). These pathogens must adapt quickly and abrogate the 
immune responses of the dermis for infection to be established. Whether vector-
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borne pathogens have special adaptations that define their interactions with the 
host in this specific layer of the skin is unknown.   
Yersinia pestis is a Gram-negative bacterium and the causative agent of 
plague. This highly virulent pathogen was responsible for major pandemics in 
history such as The Black Death (Bos et al., 2011). Y. pestis survives in animal 
reservoirs in many parts of the world, including the United States (Butler, 2013). 
Human populations that live in close proximity to plague foci are at high risk of 
infection. Bubonic plague is the most prevalent form of the disease and occurs 
after bacterial inoculation into the skin, typically by a flea vector (Wimsatt and 
Biggins, 2009). From the skin, Y. pestis disseminates to draining lymph nodes 
(LNs) via lymphatic vessels (see Chapter 3) and then to deeper organs through the 
bloodstream (Sebbane et al., 2005). Systemic dissemination results in severe 
organ failure, septicemia, and death.  
Models of infection that target the subcutaneous (SC) space are broadly used 
in plague research (Abu Khweek et al., 2010; Demeure et al., 2012; Lenz et al., 
2011; Oyston et al., 2000) as this is a fairly easy tissue to target.  However, the 
dermis is strongly suggested to be the layer of the skin probed by fleas during 
transmission (Hinnebusch, 2005; Sebbane et al., 2006). In comparison with SC 
models, ID inoculations require more dexterity and can be more challenging to 
implement in biosafety level three facilities, which are mandatory when handling 
fully virulent strains of Y. pestis. In this study, we followed the progression of 
infection after ID and SC inoculation to determine if inoculation site impacted the 
infection. We found important differences in the disease progression of wild type 
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(WT) Y. pestis. In addition, we also found a mutant strain that is attenuated 
following ID inoculation, but not after SC inoculation. These findings are relevant 
for the understanding of Y. pestis pathogenesis and host responses to different 
inoculation routes. In addition, this study sheds light into processes regarding 
antigen delivery to LNs. For this reason, our findings might be relevant to the 
implementation of new vaccine strategies.  
4.3. Methods  
4.3.1. Bacterial cultures and strains 
Fully virulent Y. pestis CO92 was used in all the experiments of this study (Doll 
et al., 1994; Parkhill et al., 2001). Bacteria were streaked on brain and heart 
infusion (BHI, BD Biosciences, Bedford MA) agar plates from frozen stocks and 
incubated at 26°C for 48 h. Liquid cultures in BHI broth were incubated for 15 h at 
26°C with aeration. The procedures employed to construct the isogenic set of 
tagged strains used in the dissemination assays are described elsewhere (see 
Chapter 3)(Walters et al., 2012). Briefly, Y. pestis was tagged with an 
oligonucleotide signature tag (along with a kanamycin resistant cassette), which 
was inserted in a neutral site in the bacterial chromosome at the Tn7 att site (Choi 
et al., 2005). We generated 10 Y. pestis tagged strains, which have similar growth 
and virulence characteristics compared to those of un-tagged bacteria. For the 
dose dependent survival assays (DDSA) an un-tagged strain was used. The 
ΔyapH strain has an in-frame deletion and was constructed with the λ Red 
recombination system, as described somewhere else (Datsenko and Wanner, 
2000; Lathem et al., 2007). Briefly, Briefly, the upstream flanking region of yapH 
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was amplified with primers DNA134/DNA135 (5’- GCA TGA TTA CAG CCA ATC 
CCA CA-3’ and 5’-GAA GCA GCT CCA GCC TAC ACC ATA TAT AGC CTT AAC 
AAA TTT TTA ATT TGT CAA TTA AGT TG-3’, respectively) and the downstream 
flanking region was amplified with DNA136/DNA137 (5’-GGT CGA CGG ATC CCC 
GGA ATA ATT TTA TCG TCA GGT AAT TAA CCA CTA ACG ACA-3’ and 5’-CGC 
TTC TTT GGC GTA TCA CAT-3’, respectively). The primers DNA135 and DNA136 
add recognition sites for FLP recombinase to their respective PCR products. These 
flanking regions were then joined with a kanamycin resistance cassette (KanR) by 
overlap extension PCR to obtain the resulting yapH5’-FRT-KanR-FRT-yapH3’ 
product. Wild type Y. pestis expressing the λ Red recombinase gene (from 
pWL204) was transformed with this fragment. KanR colonies were streaked on BHI 
with 10% sucrose to cure pWL204. The KanR was removed with the FRT 
recombinase (from pLH29). Deletion of yapH was confirmed by PCR.  
4.3.2. Animal inoculations 
Female C57BL/6J mice (six-to-eight week-old, Jackson Laboratory, Bar 
Harbor, ME) were inoculated with Y. pestis after injection of a ketamine/xylazine 
mix. Intradermal (ID) inoculations are described elsewhere (see Chapter 3). Briefly, 
~200 colony forming units (CFU) in 2 µL were injected into the dorsal leaflet of the 
ear pinna with the aid of a Pump11 Elite syringe pump (Harvard Apparatus, 
Holliston, MA). The same procedure was used for the subcutaneous (SC) 
inoculations except that mice were injected in the ventral cervical region (2 µL were 
also used for this route). Organs were harvested at different time points, 
homogenized, diluted and plated on BHI agar to enumerate bacteria in each organ. 
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For the ID inoculations, the superficial parotid lymph nodes were harvested (Van 
den Broeck et al., 2006). For the SC inoculations, the superficial cervical lymph 
nodes were harvested.  
For the assay to determine the presence of a bottleneck, 9 of the 10 tagged 
strains were grown in BHI broth with 25 µg/mL kanamycin. After standardizing all 
cultures based on optical density at 600 nm (OD600), equal amounts of each culture 
were mixed in a tube. The mix was serially diluted in PBS to obtain an inoculum 
equivalent to ~200 CFU. The tenth tagged strain was omitted from the mix so it 
could be used as a negative control.  Recovered bacteria were used for DNA 
extraction and this DNA was then used as a probe for Southern dot blot (see 
Chapter 3). Statistical analysis was performed using a Mann Whitney test 
calculated by GraphPad Prism version 4.0c for Macintosh (GraphPad Software, La 
Jolla, CA). We established statistical significance at p < 0.05.  
4.4. Results  
4.4.1. The ID inoculations result in faster kinetics but lower mortality rates when 
compared with SC inoculations 
We recently reported the presence of a bottleneck during ID but not SC 
inoculations of Y. pestis in mice (see Chapter 3). We hypothesized that 
inoculations into these layers of the skin would also affect disease progression. To 
test this, mice were inoculated ID or SC, and bacterial loads in LNs and spleens at 
48 hours post infection (hpi) were compared (Figure 4.1A). The median value of 
bacterial burden in LNs of mice inoculated ID was ~100-fold higher than the 
median value of bacterial burden in LNs of mice inoculated SC. This difference was 
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determined to be statistically significant (Mann-Whitney test, p = 0.0002). Bacteria 
burdens in the spleen, an organ used to assess systemic dissemination, showed 
an even larger difference between groups. The median value of bacterial burden in 
spleens from mice inoculated ID was ~106-fold higher than in mice inoculated SC. 
This difference also was determined to be statistically significant (Mann-Whitney 
test, p = 0.0001). From this, we predicted that the inoculation route would also 
impact survival. A dose dependent survival assay (DDSA) was used to determine 
differences in survival times for each of the inoculation routes. A DDSA can also 
reveal how these differences are influenced by the size of the inocula. Mice were 
inoculated ID with a low [~7 colony forming units (CFU)], medium (~71 CFU) or 
high (~710 CFU) inoculum and survival was monitored during the following 14 
days. The survival percentage of the mice inoculated with the low inoculum was 
67% (Figure 4.1B). Survival rates of mice inoculated with the medium and high 
inocula were 25% and 0%, respectively. For the whole group, death was first 
observed at day 2. Most mice died between days two and four, with the exception 
of one mouse from the low inoculum group, which died on day 11. For inoculation 
by the SC route, the low, medium, and high inocula were ~24 CFU, ~240 CFU, and 
~2400 CFU, respectively. No mice inoculated SC survived (Figure 4.1C). With the 
exception of one mouse in the high inoculum group that died at day 3.5, all mice 
died between days 4.5 and 7. These data indicate that the route of inoculation has 
an effect on the kinetics of infection. In addition, they suggest that Y. pestis survival 
is less compromised in response to ID inoculations in comparison with SC 
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inoculations. However, mouse survival after ID inoculation, but not after SC 
inoculation, appeared to be strictly linked to inoculum size. 
4.4.2. A deletion mutant lacking a putative autotransporter protein is attenuated 
when inoculated ID but not SC 
YapH is a 3705-amino acid putative autotransporter protein located in a 
pathogenicity island of Y. pestis (Deng et al., 2002; Yen et al., 2007). It has 21% 
identity in sequence with a gene that encodes an adhesin autotransporter of 
Haemophilus influenzae (Yen et al., 2007), but its function in Y. pestis is unknown. 
The expression of yapH is upregulated in vivo during bubonic and pneumonic 
plague (Lenz et al., 2011), a measure that is often interpreted as indicating a role 
during infection.  Thus, we predicted YapH to be important for Y. pestis 
pathogenesis during bubonic plague. To test this, we inoculated mice with wild type 
(WT) or a yapH deletion mutant (ΔyapH) strain using a SC route of inoculation. We 
compared bacterial loads in LNs and spleens from mice inoculated with each strain 
at 36, 60, and 72 hpi. This allowed us to evaluate early and late stages of infection 
based on the kinetics for our SC model of inoculation (Lane et al., 2013; Weening 
et al., 2011). None of the tissues showed a significant difference in bacterial loads 
between mice inoculated with WT or ΔyapH strains, suggesting YapH does not 
play a critical role during bubonic plague (Figure 4.2A). Because we noted that the 
formation of a bottleneck to dissemination of Y. pestis to the LN was only observed 
following Y. pestis inoculation into the dermis (see Chapter 3), we decided to test 
whether the ΔyapH strain would show the same phenotype when inoculated ID. 
We used time points relevant to the kinetics for this route (24 and 48 hpi) and, in 
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addition to LNs and spleens, we also harvested ears (site of inoculation). At 24 hpi, 
LNs from ΔyapH-inoculated mice showed a slightly lower median than WT-
inoculated mice, but this difference was not statistically significant (Figure 4.2B). 
However, at 48 hpi, a statistically significant difference was observed: lower 
burdens were observed in LNs, spleens and ears of mice inoculated with ΔyapH in 
comparison to mice inoculated with the WT strain (Figure 4.2C). Overall, these 
data suggest that the inoculation route can affect the dissemination or colonization 
of a deletion mutant (in this case ΔyapH) revealing attenuation in one route (ID) but 
not in the other (SC).  
4.4.3. A SC route of inoculation reveals a bottleneck in bacterial dissemination from 
LN to blood 
The use of oligonucleotide-tagged strains was used in our laboratory to 
identify a bottleneck to draining LNs following ID inoculation (see Chapter 3). We 
found that only a fraction of the tagged strains were present in LNs suggesting the 
bottleneck impacted bacterial dissemination from skin to LN. We also found that 
this bottleneck was less prevalent after SC inoculations, as most of the tagged 
strains were found in LNs when using this route. Because LNs of mice inoculated 
SC show most of the tagged strains (Figure 4.3A) we have enough tagged strains 
in that tissue to determine whether or not a bottleneck exists further downstream in 
the dissemination from LN to blood. Mice were inoculated SC with the nine tagged 
strains and LNs and spleens were harvested at 48 hpi. Seven out of eight mice had 
bacteria in the spleen, and six of these mice had fewer tagged strains in the 
spleens than in the LNs (Figure 4.3B). The number of strains present in the LN but 
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absent in the spleen ranged from one to seven. Interestingly, we observed two 
mice with tagged strains in the spleen that were not present in the LN. One of 
these had no detectible bacteria in the LN, but had two tagged strains present in 
the spleen. The second mouse had one strain in the spleen that was absent in the 
LN. Overall, these data indicate the existence of a bottleneck in the dissemination 
of Y. pestis from the LN into the bloodstream following a SC inoculation.  
4.5. Discussion  
Only in recent years have we begun to understand the significance of the 
differences of in vivo over in vitro approaches to study host-pathogen interactions. 
This has resulted in the development of new animal models with a goal of 
mimicking natural infections as closely as possible. However, a big limitation of 
implementing animal models is how little it is known about what aspects of a 
natural infection truly affect disease progression. In this study, we report important 
differences in progression of bubonic plague when comparing the common SC 
route and the more biologically relevant ID route.  
We observed that bacteria are able to colonize the host more efficiently after 
ID than after SC inoculations. This might be due to differences in the density and 
the anatomy of lymphatic vessels in each layer of the skin. The dermis is rich in 
terminal lymphatic vessels (O'Mahony et al., 2004). These vessels, absent in the 
epidermis and SC space, readily take up lymph and antigen due to their high 
permeability resulting from the lack of smooth muscle cells and a basal membrane 
(Shayan et al., 2006). The anatomy of terminal lymphatic vessels can explain why, 
in comparison to SC injections, dyes to map lymphatic vessels for tumor detection 
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are detected faster in LNs after ID injections (Kersey et al., 2001). In addition to 
lymphatic vessel physiology, it has also been suggested that the dermis is subject 
to high fluid pressures (O'Mahony et al., 2004). High pressures are important to 
drain fluid from the dermis to prevent edema and could also contribute to more 
efficient movement of Y. pestis to the LNs. This is especially true if, as we have 
previously suggested, Y. pestis travels to LNs freely with the flow of lymph (see 
Chapter 3). As opposed to terminal lymphatic vessels, collecting lymphatics 
possess circumferential smooth muscle cells and a basement membrane (Shayan 
et al., 2006). These two elements restrict the access of particles into the lumen and 
make them less efficient in antigen uptake. Interestingly, collecting lymphatics are 
found in the SC layer of the skin and not in the dermis. Thus, this suggests that Y. 
pestis cannot access LNs through lymphatic vessels when deposited in the SC 
space as easily as when deposited into the dermis. 
Intriguingly, we found that while the kinetics of infection are faster when Y. 
pestis is delivered into the dermis, some mice survive after ID inoculation but none 
after SC inoculation. This is more evident when low inocula are used. Most mice 
survived after inoculation of 7 CFU in the dermis and none after inoculation of a 
very similar dose (24 CFU) in the SC space. We recently reported the formation of 
a bottleneck during ID inoculation of Y. pestis and its abrogation during SC 
inoculation (see Chapter 3). We reported in the same study that a small percentage 
of ID inoculated mice did not show any bacteria in LNs and spleens, and we 
interpreted this as an indication of a highly efficient bottleneck. It would be 
expected that the effects of a barrier (i.e. bottleneck) that limits dissemination to 
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LNs are stronger when few bacteria are inoculated, and weaker when larger 
numbers of bacteria are used. Consequently, all mice inoculated ID with the higher 
inoculum (~710 CFU) died and most of the mice inoculated with the lowest 
inoculum (~7 CFU) survived.  As opposed to the dermis, the SC layer of the skin 
possesses a very limited number of resident cells of the immune response 
(Combadiere and Liard, 2011). In addition, the SC space is less vascularized than 
the dermis and, thus, access to it by infiltrating immune cells might be less efficient 
(Combadiere and Liard, 2011; Teunissen et al., 2012). We speculated that a less 
efficient immune response might account for abrogation of the bottleneck after SC 
inoculation (see Chapter 3). A less efficient immune response could allow for local 
bacterial replication in the SC space, resulting in more bacteria moving to the LNs. 
Another observation we made is the attenuation of a deletion mutant after ID 
but not SC inoculation. We believe this might be due to a role of YapH in bacterial 
adaptation to the immune response of the dermis, where different insults than 
those found in the SC space are faced. While many aspects of the anatomy and 
physiology of the different layers of the skin are understood, their effects on the 
immune response to pathogens are not clear. However, studies in the cancer and 
vaccine development fields have shed some light on this. Bonnotte and 
collaborators found that injection of a tumorigenic cell line results in tumor 
formation after SC but not ID injection in rats (Bonnotte et al., 2003). In another 
study, injection of a virus like particle to test its immunogenicity found more LN 
involvement and cellular response after ID injections when compared with SC 
delivery (Cubas et al., 2009). In addition, results favoring the use of ID, and not SC, 
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inoculation have been reported in experiments using an HIV1 antigen in vaccine 
development against this virus (Liard et al., 2011). Much less work has been done 
comparing routes of inoculation during cutaneous infections caused by vector-
borne pathogens. One exception is the work done with Leishmania parasites where 
the use of an ID route was strongly suggested to recreate disease progression 
more accurately than a SC route (Belkaid et al., 1998). These studies indicate that 
the different layers of the skin vary considerably in the immune responses they can 
elicit. Differences in the immune response might account for the different 
phenotypes the ΔyapH strain showed after inoculation in each layer of the skin. In 
addition to insights into the function of yapH, our experiments might have important 
implications for other studies in bacterial pathogenesis. Our experiments suggest 
that when testing mutants, unless using the appropriate model, not observing a 
phenotype might simply be the result of confounding effects of the model itself. 
Lastly, while we support the use of an ID model of inoculation, we believe the 
SC model should be considered as a tool to help reveal the function of a bacterial 
gene or of a specific component of the immune response. An example of an 
advantage of using the SC model as a tool is the observation of a bottleneck in 
bacterial dissemination from LN to blood. In the presence of a strong bottleneck 
after ID inoculation, only a few tagged strains survive in the LN. Consequently it is 
difficult to determine if a bottleneck occurs in the dissemination from LN to blood 
because very few strains are present in the LN. The SC inoculation route allowed 
us to have a higher number of tagged strains in the LN. This made it possible to 
assess whether some of these tagged strains were lost as disease progresses into 
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the bloodstream. A caveat is that we do not know with certainty how many bacteria 
of each tagged strain inoculated SC reach the LNs. Regardless, we know that 
many of the strains that reach the LN compartment are not found systemically. We 
believe this is enough evidence to support the existence of a bottleneck from LN to 
blood. Because the strains that were absent in the spleens were present in the 
LNs, the bottleneck is not caused by elimination of strains in the LN. Most likely, 
the bottleneck is caused by restricted movement of bacteria from LN into the 
bloodstream. Interestingly, and contrary to what we observed during ID-induced 
bottleneck in previous studies (see Chapter 3), some strains were found 
systemically and not in LNs. This could be due to (1) direct movement of bacteria 
from the SC site of inoculation into blood, or (2) killing of the remaining members of 
these strains in the lymph node after a fraction of them escaped to the 
bloodstream. More experiments would be needed to clarify this aspect of the SC 
model.  
Overall, we believe that studies that explore the skin in an infection context are 
extremely valuable for fields as diverse as vector borne pathogenesis, cutaneous 
immunology, and vaccine development. For vector borne infections, including 
bubonic plague, well-established models might need to be revisited and new 
models might need to be considered. Findings that derive from well-established 
models that have not been appropriately tested might reflect confounding effects of 
the model rather than biologically relevant observations.  
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4.6. Figure and Tables 
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Figure 4.1. Kinetics of infection and survival in mice inoculated ID and SC.  
(A) CFU from LNs (circles) and spleens (squares) harvested 48 hours after ID 
(black symbols) or SC (white symbols) inoculation. Each symbol represents the 
number of CFU obtained from a tissue. The horizontal lines depict the median of 
the group. Statistically significant differences between groups were determined by 
a Mann-Whitney test, establishing significance at p < 0.05. The dotted line shows 
the limit of detection. (B and C) DDSA of mice inoculated ID (B) or SC (C) using 
three different inocula. A low inoculum is represented with a dotted line, a medium 
inoculum with a gray continuous line, and a high inoculum with a black continuous 
line. Each line depicts the percentage of mice surviving in a group (n=8 per 
inoculum for ID, n=6 per inoculum for SC) at different time points (in days). 
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Figure 4.2. Kinetics of infection of a deletion mutant (ΔyapH) after ID and SC 
inoculation.  
(A) CFU from LNs (circles) and spleens (squares) harvested at 36, 60, and 72 
hours after SC inoculation with WT (black symbols) or ΔyapH (white symbols) Y. 
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pestis. (B and C) CFU from LNs (circles), spleens (squares), and ears (triangles) 
harvested at 24 (B) and 48 (C) hours after ID inoculation with WT (black symbols) 
or ΔyapH (white symbols) Y. pestis. Each symbol represents the number of CFU 
obtained from a tissue. The horizontal lines depict the median of the group. 
Statistically significant differences between groups were determined by a Mann-
Whitney test, establishing significance at p < 0.05. The dotted line shows the limit 
of detection.  
 
 
 
Figure 4.3. A bottleneck from LN to spleen revealed after SC inoculation.  
(A) Southern dot blot of bacterial DNA obtained from the LNs of mice inoculated 
SC with nine oligonucleotide tagged strains of Y. pestis. Each row depicts the 
results from a single mouse. Each strain is identified (A1 to 5 and B1 to 4; A6 was 
used as a negative control). (B) Results of Southern dot blots analogous to those 
shown in (A) are represented pictorially. Tagged strains are shown as present 
(gray) or absent (white). The “+” symbol represents tagged strains present in LNs 
that are absent in spleens. The “X” symbol represents tagged strains absent in LNs 
and present in spleens.  
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CHAPTER 5: DISCUSSION 
5.1. Summary of main findings 
The traditional approach to study Y. pestis dissemination includes harvesting 
organs from infected animals to establish bacterial burden at a determined time 
point. In Chapter 2, I described a non-invasive approach to track bacterial 
dissemination in mice. With this technique, mice are inoculated with bioluminescent 
Y. pestis, and the presence of the bacteria in multiple organs can be assessed by 
bioluminescence imaging technology. The non-invasive nature of this in vivo 
imaging approach allows for the use of the same group of mice over different time 
points. This results in accurate observations of the progression of infection and 
strong statistical power to analyze them. We showed that this technique works 
efficiently for intradermal and subcutaneous models of bubonic plague, as well as 
for an intranasal model for pneumonic plague. In addition, we showed that 
bioluminescent imaging technology is suitable for characterizing Y. pestis mutants 
with defects in dissemination or colonization (Gonzalez et al., 2012).  
One large gap in the field is an understanding of how Y. pestis interacts with 
the host during dissemination. In Chapter 3, I described important events that occur 
upon inoculation and that have the potential to define the outcome of infection. 
These events include formation of a bottleneck that restricts the passage of 
bacteria as they disseminate form the skin to lymph nodes. I also described host-
pathogen interactions of Y. pestis throughout infection, at a cellular level, by 
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microscopy imaging. This approach, along with neutrophil depletion, allowed us to 
uncover that neutrophils control bacterial growth in the skin. In addition, we showed 
bacterial interaction with both neutrophils and platelets in the bloodstream.   
Finally, in Chapter 4 I described how the use of an intradermal model of 
infection might be more relevant for the study of bubonic plague than traditional 
subcutaneous models. In comparison with a subcutaneous model, an intradermal 
model resulted in faster progression of infection. In addition, a deletion mutant 
lacking a gene of unknown function was attenuated after inoculation using an 
intradermal route. This same mutant colonizes tissues equally when compared with 
wild type Y. pestis when inoculated using a subcutaneous route. 
5.2. Implications for the study of bubonic plague 
The study of host-pathogen interactions during bubonic plague has largely 
been conducted using in vitro approaches. The emphasis on in vitro studies is 
largely due to the availability of cell lines and also because of the complications 
that working with animal models entail. Another element that has characterized 
plague research is the use of attenuated strains. Work with fully virulent Y. pestis is 
restricted to biosafety level three laboratories, which are expensive to maintain and 
not available at most institutions. As a consequence, most of the ideas we have 
about Y. pestis host-pathogen interactions derive from models that are missing one 
or many key elements of infection.  
Because we conducted all our experiments in vivo and using a fully virulent 
strain of Y. pestis, our observations are more biologically relevant, as the major 
elements of infection are taken into account. We identified many previously 
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unrecognized events that define bacterial dissemination and colonization of the 
host. These events include the formation of a bottleneck during Y. pestis 
dissemination as well as neutrophil-dependent restriction of bacterial growth in the 
skin. We also provided images of bacteria as they disseminate through multiple 
tissues. This provided new information on the nature of host-pathogen interactions, 
such as bacterial association with host cells in lymphatic vessels and with 
neutrophils and platelets in the bloodstream.  
Besides the novel observations we report, we believe that the techniques that 
were developed to make these observations will be of relevance to the field for 
future studies. Our microscopy approach allows for direct qualitative observations 
of host-pathogen interactions without compromising the use of fully virulent strains. 
This method serves as a reliable approach that can be implemented for the study 
of specific mutants to gain insights into the function of specific bacterial genes.  
Lastly, we modified a previously described murine intradermal model of 
infection to study bubonic plague (Guinet and Carniel, 2003). We provided 
information that revealed biologically relevant differences between this intradermal 
model and a more widely used subcutaneous approach. The observed differences 
strongly suggest that an intradermal model should be considered over 
subcutaneous models to study bubonic plague.  
We believe that the use of the aforementioned approaches provide valuable 
new tools to improve our understanding of Y. pestis interactions with the host.  
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5.3. Caveats of our intradermal model of infection  
Our intradermal model of infection is based on the injection of a very small 
volume into the dermis of the mouse ear. Previously reported models use 
considerably larger volumes, which result in significant disruption of the dermis 
(Guinet and Carniel, 2003; Spinner et al., 2013). One of the advantages of the use 
of smaller volumes is that it allowed for accurate observations by microscopy 
imaging. The use of larger volumes causes major disruption of the skin, which can 
result in confounding effects when assessing bacterial interactions with the host in 
this tissue.  More importantly, the use of smaller volumes eliminated confounding 
effects related to bacterial growth that derived from disruption of the dermis 
(Shannon et al., 2013). While we are confident that our approach very closely 
mimics an infectious fleabite, we believe that many modifications should still be 
explored.  
Models where needles are used to deliver bacteria instead of a fleabite are 
unavoidable because it is impossible to control the number of bacteria inoculated 
when using flea models. While the caveats of needle delivery are many, we think 
two of them are of major importance. The first caveat is related to the disruption of 
dermal tissue an injection causes in comparison with a fleabite. Disruption to the 
dermis by the volume injected by a fleabite might be minimal, if not negligible. 
While we inject a very small volume (2 µL), this still causes some damage to the 
dermis, in addition to mechanical damage derived from the needle itself. An 
alternative to minimize skin disruption could be to deposit the same inoculum (2 µL) 
on the tip of a needle and puncture the dermis with it. This would deliver bacteria 
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without forcing a volume of liquid to penetrate into the skin. Plating homogenized 
ears immediately after inoculation can easily be used to assess the accuracy of this 
method to deliver a desired inoculum. The second caveat is that saliva components 
and other molecules present in the mouthparts of the flea are absent during needle 
inoculations (Belkaid et al., 1998). Saliva components of arthropods have been 
shown to influence the progression of infection during vector borne diseases 
(Bizzarro et al., 2013; Leitner et al., 2013). For this reason, the absence of flea 
saliva might be the most important caveat of needle infections when attempting to 
mimic a fleabite. This caveat has been partially addressed in other fields with great 
success. Salivary glands of sand flies have been inoculated along with Leishmania 
parasites in a model that reproduced previously unattainable clinical signs of 
cutaneous leishmaniasis (Belkaid et al., 1998; Peters et al., 2009). Establishing 
similar approaches in the plague field would be important to determine whether the 
observations reported by us or other groups are a true recapitulation of flea-
inoculated infections. 
An additional limitation is the use of a single animal species. Y. pestis has 
multiple hosts and their role in maintenance of plague is not well established. 
Rodents have been shown to be relevant for bacterial maintenance in sylvatic 
plague and thus they make an ideal model for the study of Y. pestis (Gage and 
Kosoy, 2005). However, much genetic variability exists within this multispecies 
group of animals. The implications of this were shown in an study where deletion 
mutants were shown to behave differently when tested in different mouse 
backgrounds (Weening et al., 2011). A promising alternative is the use of mouse 
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systems that encompass variable genetic backgrounds (termed the Collaborative 
Cross) (Churchill et al., 2004). These systems might better reflect the diverse gene 
pool Y. pestis is exposed to in its different hosts.  
Beyond the above-mentioned limitations, much can be learned from any in 
vivo model that is not limited by the use of attenuated strains. The use of animal 
models to study Y. pestis pathogenesis is extremely promising and there are still 
many aspects of these models that have not been explored. Murine models in 
particular provide a remarkable advantage in plague studies when compared to 
other fields. This advantage is that, along with rats, mice are natural hosts. This 
means that much of what is learned through murine models of infection should 
closely recapitulate many, if not all, of the important components present during a 
natural infection.  
5.4. Understudied aspects of Y. pestis dissemination.  
This body of work has provided new windows to take a direct look at 
fundamental aspects of dissemination and pathogenesis of Y. pestis that are 
currently understudied. Three aspects are worth mentioning and require urgent 
attention for the field to advance. The first aspect is bacterial colonization of the 
lymph node. We showed that bacterial growth is severely restricted in the ear most 
likely by the action of neutrophils. A striking change seems to occur once bacteria 
reach the lymph node as they grow profusely in this compartment. This could result 
from the absence of growth-restrictive immune responses in the lymph node, a 
component of lymph node tissue that triggers bacterial growth, or a combination of 
both. It is easy to propose that the bacterium must be equipped with specific genes 
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that allow for such a dramatic change in growth from one tissue to the next. Neither 
host nor bacterial components that could explain this phenomenon have been 
reported.  
A second aspect that is understudied is bacterial migration from the lymph 
node into the bloodstream. Fatalities during plague infections are caused by the 
effects of bacteria in the bloodstream, and thus, most research efforts should be 
devoted to address this systemic stage of disease. It is currently unknown what 
mechanisms the bacteria use to escape the lymph node, an organ whose function 
is precisely to prevent pathogens from moving into the bloodstream. Escape could 
occur in a direct manner if Y. pestis is able to actively invade the high endothelial 
venules that enter lymph nodes and allow for easy access of leukocytes to this 
compartment. Because infected lymph nodes are enlarged and bloody, we believe 
that entrance to the high endothelial veins might occur as the bacteria disrupt the 
normal architecture of this compartment. An alternative mechanism could involve 
bacterial escape through efferent lymphatic vessels. These vessels collect the 
lymph that is filtered by a lymph node and conduct it to the thoracic duct. The 
thoracic duct drains into the left subclavian vein, which serves as a direct entry into 
systemic circulation. The disruption of the normal functions of the lymph node to 
prevent further bacterial dissemination is one of the most relevant abilities of Y. 
pestis to cause disease. For this reason, insights into the mechanisms that result in 
lymph node escape are imperative to fully understand Y. pestis pathogenesis.  
Lastly, the study of Y. pestis during septicemic stages is the most neglected 
aspect of plague research and it is limited to a very modest number of studies 
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(Chauvaux et al., 2007; Zhou et al., 2013). This is contradictory to what would be 
expected since the presence of bacteria in the bloodstream is the actual cause of 
death for bubonic plague patients. Aspects of the septicemic stages of infection 
that need critical attention are (1) interactions with cells of the innate immune 
response, (2) bacteria-induced damage to endothelial tissue, and (3) bacterial 
mechanisms that elicit septic shock. We partially addressed some of these aspects 
by providing tools to visualize bacteria in the bloodstream. Even though we limited 
our studies to the observation of neutrophils and platelets, additional antibodies 
can be used to assess interactions with other host cells.  
Many important aspects of the host-pathogen interactions that occur during Y. 
pestis infections are understudied. Addressing these understudied aspects of Y. 
pestis pathogenesis and providing mechanisms that explain them is the first step to 
proposing strategies to control disease. 
5.4. Translational implications and impact to other fields 
During these studies we followed multiple components of the host as it 
attempts to control bacterial spread during bubonic plague. We took a closer look 
at cutaneous immunity and showed the role of neutrophils in controlling bacterial 
growth in the skin. We also reported the presence of a bottleneck that limits 
bacterial spread from the skin into the lymph nodes and from lymph nodes into the 
bloodstream. These constitute efforts by the host to control Y. pestis. These efforts 
could be exploited in clinical settings to prevent disease progression in exposed 
individuals. More importantly, the microscopy approaches we implemented to study 
bacterial dissemination can easily be used to address questions relevant to 
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cutaneous immunology. This is not limited to Y. pestis, or even, bacterial infections 
but could be extended to other infectious diseases, autoimmune disorders or even 
cancer. Moreover, vaccine development could directly be influenced by our work. 
Cutaneous immunity, cutaneous physiology, antigen transport, and host-pathogen 
interactions in the skin, are aspects of our research with biologically relevant 
implications to vaccine development. Our work might be of importance not only for 
the improved understanding of bubonic plague, but could also contribute to efforts 
to prevent and control other infectious diseases that are relevant to public health.  
5.4. Future experiments 
The list bellow contains future directions that can serve as a guide to continue 
with this work.  
1. Determine whether the bottlenecks are present after inoculation of other 
bacteria. A comparison between Y. pestis and species that are closely 
related to it (e.g. Y. pesudotuberculosis) and species that are not related 
(e.g. Francisella tularensis) can be made.  
2. Determine whether the absence of a bottleneck after SC injection 
replicates from other anatomical sites in the mouse (e.g. back or leg).  
3. Determine whether the neutrophils in the skin that interact with Y. pestis 
are targeted by the bacteria’s type 3 secretion system apparatus.  
4. Determine bacterial associations with host cells in the lymph node. 
5. Establish whether bacteria can be found in afferent lymph vessels and 
the thoracic duct. 
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6. Determine whether the neutrophil-platelet-bacterial associations 
observed during bacteremia are Y. pestis specific or if they can occur 
with other bacteria as well.  
7. Establish the role of neutrophils and platelets during bacteremia. 
8. Establish if there is tissue damage during bacteremia (e.g. endothelium) 
and if it is bacteria or host dependent.  
9. Assess the role of other cells of the immune response through 
microscopy imaging of mice with fluorescently labeled immune cells.  
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